<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35205380</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>20</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2073-4425</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>13</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Feb</Month>
              <Day>11</Day>
            </PubDate>
          </JournalIssue>
          <Title>Genes</Title>
          <ISOAbbreviation>Genes (Basel)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Smith-Magenis Syndrome-Clinical Review, Biological Background and Related Disorders.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">335</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/genes13020335</ELocationID>
        <Abstract>
          <AbstractText>Smith-Magenis syndrome (SMS) is a complex genetic disorder characterized by distinctive physical features, developmental delay, cognitive impairment, and a typical behavioral phenotype. SMS is caused by interstitial 17p11.2 deletions (90%), encompassing multiple genes and including the retinoic acid-induced 1 gene (<i>RAI1</i>), or by pathogenic variants in <i>RAI1</i> itself (10%). <i>RAI1</i> is a dosage-sensitive gene expressed in many tissues and acting as transcriptional regulator. The majority of individuals exhibit a mild-to-moderate range of intellectual disability. The behavioral phenotype includes significant sleep disturbance, stereotypes, maladaptive and self-injurious behaviors. In this review, we summarize current clinical knowledge and therapeutic approaches. We further discuss the common biological background shared with other conditions commonly retained in differential diagnosis.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rinaldi</LastName>
            <ForeName>Berardo</ForeName>
            <Initials>B</Initials>
            <Identifier Source="ORCID">0000-0001-5763-5347</Identifier>
            <AffiliationInfo>
              <Affiliation>Clinical Genetics Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Villa</LastName>
            <ForeName>Roberta</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Genetics Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sironi</LastName>
            <ForeName>Alessandra</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-3997-8810</Identifier>
            <AffiliationInfo>
              <Affiliation>Experimental Research Laboratory of Medical Cytogenetics and Molecular Genetics, Istituto Auxologico Italiano, IRCCS, 20145 Milan, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Segrate, 20090 Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Garavelli</LastName>
            <ForeName>Livia</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Genetics Unit, Azienda USL-IRCCS of Reggio Emilia, 42123 Reggio Emilia, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Finelli</LastName>
            <ForeName>Palma</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0001-8464-6906</Identifier>
            <AffiliationInfo>
              <Affiliation>Experimental Research Laboratory of Medical Cytogenetics and Molecular Genetics, Istituto Auxologico Italiano, IRCCS, 20145 Milan, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Segrate, 20090 Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bedeschi</LastName>
            <ForeName>Maria Francesca</ForeName>
            <Initials>MF</Initials>
            <Identifier Source="ORCID">0000-0002-6723-9177</Identifier>
            <AffiliationInfo>
              <Affiliation>Clinical Genetics Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Genes (Basel)</MedlineTA>
        <NlmUniqueID>101551097</NlmUniqueID>
        <ISSNLinking>2073-4425</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D015534">Trans-Activators</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008607" MajorTopicYN="Y">Intellectual Disability</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058496" MajorTopicYN="Y">Smith-Magenis Syndrome</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015534" MajorTopicYN="N">Trans-Activators</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">17p11.2 deletion syndrome</Keyword>
        <Keyword MajorTopicYN="Y">RAI1</Keyword>
        <Keyword MajorTopicYN="Y">SMS</Keyword>
        <Keyword MajorTopicYN="Y">Smith-Magenis</Keyword>
        <Keyword MajorTopicYN="Y">sleep disorders</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>25</Day>
          <Hour>1</Hour>
          <Minute>6</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35205380</ArticleId>
        <ArticleId IdType="pmc">PMC8872351</ArticleId>
        <ArticleId IdType="doi">10.3390/genes13020335</ArticleId>
        <ArticleId IdType="pii">genes13020335</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Allanson J.E., Greenberg F., Smith A.C.M. The Face of Smith-Magenis Syndrome: A Subjective and Objective Study. J. Med. Genet. 1999;36:394–397. doi: 10.1136/jmg.36.5.394.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jmg.36.5.394</ArticleId>
            <ArticleId IdType="pmc">PMC1734375</ArticleId>
            <ArticleId IdType="pubmed">10353786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith A.C.M., McGavran L., Robinson J., Waldstein G., Macfarlane J., Zonona J., Reiss J., Lahr M., Allen L., Magenis E. Interstitial Deletion of (17)(p11.2p11.2) in Nine Patients. Am. J. Med. Genet. 1986;24:393–414. doi: 10.1002/ajmg.1320240303.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.1320240303</ArticleId>
            <ArticleId IdType="pubmed">2425619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greenberg F., Guzzetta V., De Oca-Luna R.M., Magenis R.E., Smith A.C.M., Richter S.F., Kondo I., Dobyns W.B., Patel P.I., Lupski J.R. Molecular Analysis of the Smith-Magenis Syndrome: A Possible Contiguous-Gene Syndrome Associated with del(17)(p11.2) Am. J. Hum. Genet. 1991;49:1207–1218.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1686451</ArticleId>
            <ArticleId IdType="pubmed">1746552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith A.C.M., McGavran L., Waldstein G. Deletion of the 17 Short Arm in Two Patients with Facial Clefts. Am. J. Med. Genet. 1982;34:410A.</Citation>
        </Reference>
        <Reference>
          <Citation>Slager R.E., Newton T.L., Vlangos C.N., Finucane B., Elsea S.H. Mutations in RAI1 Associated with Smith-Magenis Syndrome. Nat. Genet. 2003;33:466–468. doi: 10.1038/ng1126.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng1126</ArticleId>
            <ArticleId IdType="pubmed">12652298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith A.C.M., Boyd K.E., Brennan C., Charles J., Elsea S.H., Finucane B.M., Foster R., Gropman A., Girirajan S., Haas-Givler B. Smith-Magenis Syndrome.  [(accessed on 9 December 2021)];GeneReviews® [Internet]  Available online:  https://www.ncbi.nlm.nih.gov/books/NBK1310/</Citation>
        </Reference>
        <Reference>
          <Citation>Smith A.C.M., Magenis R.E., Elsea S.H. Overview of Smith-Magenis Syndrome. J. Assoc. Genet. Technol. 2005;31:163–167.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16354942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edelman E.A., Girirajan S., Finucane B., Patel P.I., Lupski J.R., Smith A.C.M., Elsea S.H. Gender, Genotype, and Phenotype Differences in Smith-Magenis Syndrome: A Meta-Analysis of 105 Cases. Clin. Genet. 2007;71:540–550. doi: 10.1111/j.1399-0004.2007.00815.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1399-0004.2007.00815.x</ArticleId>
            <ArticleId IdType="pubmed">17539903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greenberg F., Lewis R.A., Potocki L., Glaze D., Parke J., Killian J., Murphy M.A., Williamson D., Brown F., Dutton R., et al.  Multi-Disciplinary Clinical Study of Smith-Magenis Syndrome (Deletion 17p11.2) Am. J. Med. Genet. 1996;62:247–254. doi: 10.1002/(SICI)1096-8628(19960329)62:3&lt;247::AID-AJMG9&gt;3.0.CO;2-Q.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1096-8628(19960329)62:3&lt;247::AID-AJMG9&gt;3.0.CO;2-Q</ArticleId>
            <ArticleId IdType="pubmed">8882782</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elsea S.H., Girirajan S.S. Smith-Magenis Syndrome. Eur. J. Hum. Genet. 2008;16:412–421. doi: 10.1038/sj.ejhg.5202009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.ejhg.5202009</ArticleId>
            <ArticleId IdType="pubmed">18231123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Girirajan S., Elsas L.J., Devriendt K., Elsea S.H. RAI1 Variations in Smith-Magenis Syndrome Patients without 17p11.2 Deletions. J. Med. Genet. 2005;42:820–828. doi: 10.1136/jmg.2005.031211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jmg.2005.031211</ArticleId>
            <ArticleId IdType="pmc">PMC1735950</ArticleId>
            <ArticleId IdType="pubmed">15788730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guérin-Moreau M., Colin E., Nguyen S., Andrieux J., De Leersnyder H., Bonneau D., Martin L. Dermatologic Features of Smith-Magenis Syndrome. Pediatr. Dermatol. 2015;32:337–341. doi: 10.1111/pde.12517.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/pde.12517</ArticleId>
            <ArticleId IdType="pubmed">25684097</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen R.M., Lupski J.R., Greenberg F., Lewis R.A. Ophthalmic Manifestations of Smith-Magenis Syndrome. Ophthalmology. 1996;103:1084–1091. doi: 10.1016/S0161-6420(96)30563-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0161-6420(96)30563-0</ArticleId>
            <ArticleId IdType="pubmed">8684798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finucane B.M., Jaeger E.R., Kurtz M.B., Weinstein M., Scott C.I. Eye Abnormalities in the Smith-Magenis Contiguous Gene Deletion Syndrome. Am. J. Med. Genet. 1993;45:443–446. doi: 10.1002/ajmg.1320450409.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.1320450409</ArticleId>
            <ArticleId IdType="pubmed">8465847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gropman A.L., Duncan W.C., Smith A.C.M. Neurologic and Developmental Features of the Smith-Magenis Syndrome (del 17p11.2) Pediatr. Neurol. 2006;34:337–350. doi: 10.1016/j.pediatrneurol.2005.08.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pediatrneurol.2005.08.018</ArticleId>
            <ArticleId IdType="pubmed">16647992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen K.S., Potocki L., Lupski J.R. The Smith-Magenis Syndrome [del(17)p11.2]: Clinical Review and Molecular Advances. Ment. Retard. Dev. Disabil. Res. Rev. 1996;2:122–129. doi: 10.1002/(SICI)1098-2779(1996)2:3&lt;122::AID-MRDD2&gt;3.0.CO;2-U.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1098-2779(1996)2:3&lt;122::AID-MRDD2&gt;3.0.CO;2-U</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tomona N., Smith A.C.M., Guadagnini J.P., Hart T.C. Craniofacial and Dental Phenotype of Smith-Magenis Syndrome. Am. J. Med. Genet. Part A. 2006;140:2556–2561. doi: 10.1002/ajmg.a.31371.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.31371</ArticleId>
            <ArticleId IdType="pubmed">17001665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Di Cicco M., Padoan R., Felisati G., Dilani D., Moretti E., Guerneri S., Selicorni A. Otorhinolaringologic Manifestation of Smith-Magenis Syndrome. Int. J. Pediatr. Otorhinolaryngol. 2001;59:147–150. doi: 10.1016/S0165-5876(01)00475-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0165-5876(01)00475-X</ArticleId>
            <ArticleId IdType="pubmed">11378192</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith A.C.M., Dykens E., Greenberg F. Behavioral Phenotype of Smith-Magenis Syndrome (del 17p11.2) Am. J. Med. Genet. Neuropsychiatr. Genet. 1998;81:179–185. doi: 10.1002/(SICI)1096-8628(19980328)81:2&lt;179::AID-AJMG10&gt;3.0.CO;2-E.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1096-8628(19980328)81:2&lt;179::AID-AJMG10&gt;3.0.CO;2-E</ArticleId>
            <ArticleId IdType="pubmed">9613859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>La Guía I.H.D., Garayzábal-Heinze E., Gómez-Vilda P. Voice Characteristics in Smith–Magenis Syndrome: An Acoustic Study of Laryngeal Biomechanics. Languages. 2020;5:31.  doi: 10.3390/languages5030031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/languages5030031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Girirajan S., Vlangos C.N., Szomju B.B., Edelman E., Trevors C.D., Dupuis L., Nezarati M., Bunyan D.J., Elsea S.H. Genotype-Phenotype Correlation in Smith-Magenis Syndrome: Evidence That Multiple Genes in 17p11.2 Contribute to the Clinical Spectrum. Genet. Med. 2006;8:417–427. doi: 10.1097/01.gim.0000228215.32110.89.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.gim.0000228215.32110.89</ArticleId>
            <ArticleId IdType="pubmed">16845274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kondo I., Matsuura S., Kuwajima K., Tokashiki M., Izumikawa Y., Naritomi K., Niikawa N., Kajii T. Diagnostic Hand Anomalies in Smith-Magenis Syndrome: Four New Patients with del (17)(p11.2p11.2) Am. J. Med. Genet. 1991;41:225–229. doi: 10.1002/ajmg.1320410219.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.1320410219</ArticleId>
            <ArticleId IdType="pubmed">1785639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schlesinger A.E., Potocki L., Poznanski A.K., Lupski J.R. The Hand in Smith-Magenis Syndrome (Deletion 17p11.2): Evaluation by Metacarpophalangeal Pattern Profile Analysis. Pediatr. Radiol. 2003;33:173–176. doi: 10.1007/s00247-002-0826-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00247-002-0826-0</ArticleId>
            <ArticleId IdType="pubmed">12612815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>MarianneJensen L., Kirchhoff M. Polydactyly in a Boy with Smith-Magenis Syndrome. Clin. Dysmorphol. 2005;14:189–190. doi: 10.1097/00019605-200510000-00004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00019605-200510000-00004</ArticleId>
            <ArticleId IdType="pubmed">16155420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rive Le Gouard N., Jacquinet A., Ruaud L., Deleersnyder H., Ageorges F., Gallard J., Lacombe D., Odent S., Mikaty M., Manouvrier-Hanu S., et al.  Smith-Magenis Syndrome: Clinical and Behavioral Characteristics in a Large Retrospective Cohort. Clin. Genet. 2021;99:519–528. doi: 10.1111/cge.13906.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cge.13906</ArticleId>
            <ArticleId IdType="pubmed">33368193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crain C.A.  Master’s Thesis. University of Texas Graduate School of Biomedical Sciences; Houston, TX, USA: May, 2010. An Assessment of Obesity and Hyperphagia in Individuals with Smith-Magenis Syndrome.</Citation>
        </Reference>
        <Reference>
          <Citation>Burns B., Schmidt K., Williams S.R., Kim S., Girirajan S., Elsea S.H. RAI1 Haploinsufficiency Causes Reduced Bdnf Expression Resulting in Hyperphagia, Obesity and Altered Fat Distribution in Mice and Humans with No Evidence of Metabolic Syndrome. Hum. Mol. Genet. 2010;19:4026–4042. doi: 10.1093/hmg/ddq317.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddq317</ArticleId>
            <ArticleId IdType="pmc">PMC7714048</ArticleId>
            <ArticleId IdType="pubmed">20663924</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Potocki L., Shaw C.J., Stankiewicz P., Lupski J.R. Variability in Clinical Phenotype despite Common Chromosomal Deletion in Smith-Magenis Syndrome [del(17)(p11.2p11.2)] Genet. Med. 2003;5:430–434. doi: 10.1097/01.GIM.0000095625.14160.AB.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.GIM.0000095625.14160.AB</ArticleId>
            <ArticleId IdType="pubmed">14614393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith A.C.M., Gropman A.L.  Cassidy and Allanson’s Management of Genetic Syndromes. John Wiley &amp; Sons, Inc.; Hoboken, NJ, USA: 2021. Smith-Magenis Syndrome; pp. 863–893.</Citation>
        </Reference>
        <Reference>
          <Citation>De Leersnyder H., De Blois M.C., Claustrat B., Romana S., Albrecht U., Von Kleist-Retzow J.C., Delobel B., Viot G., Lyonnet S., Vekemans M., et al.  Inversion of the Circadian Rhythm of Melatonin in the Smith-Magenis Syndrome. J. Pediatr. 2001;139:111–116. doi: 10.1067/mpd.2001.115018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1067/mpd.2001.115018</ArticleId>
            <ArticleId IdType="pubmed">11445803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Itoh M., Hayashi M., Hasegawa T., Shimohira M., Kohyama J. Systemic Growth Hormone Corrects Sleep Disturbance in Smith-Magenis Syndrome. Brain Dev. 2004;26:484–486. doi: 10.1016/j.braindev.2004.01.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.braindev.2004.01.007</ArticleId>
            <ArticleId IdType="pubmed">15351087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spadoni E., Colapietro P., Bozzola M., Marseglia G.L., Repossi L., Danesino C., Larizza L., Maraschio P. Smith-Magenis Syndrome and Growth Hormone Deficiency. Eur. J. Pediatr. 2004;163:353–358. doi: 10.1007/s00431-004-1460-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00431-004-1460-7</ArticleId>
            <ArticleId IdType="pubmed">15138811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stratton R.F., Dobyns W.B., Greenberg F., DeSana J.B., Moore C., Fidone G., Runge G.H., Feldman P., Sekhon G.S., Pauli R.M. Interstitial Deletion of (17)(p11.2p11.2): Report of Six Additional Patients with a New Chromosome Deletion Syndrome. Am. J. Med. Genet. 1986;24:421–432. doi: 10.1002/ajmg.1320240305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.1320240305</ArticleId>
            <ArticleId IdType="pubmed">3728561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Onesimo R., Versacci P., Delogu A.B., De Rosa G., Pugnaloni F., Blandino R., Leoni C., Calcagni G., Digilio M.C., Zollino M., et al.  Smith–Magenis Syndrome: Report of Morphological and New Functional Cardiac Findings with Review of the Literature. Am. J. Med. Genet. Part A. 2021;185:2003–2011. doi: 10.1002/ajmg.a.62196.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.62196</ArticleId>
            <ArticleId IdType="pubmed">33811726</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chou I.C., Tsai F.J., Yu M.T., Tsai C.H. Smith-Magenis Syndrome with Bilateral Vesicoureteral Reflux: A Case Report. J. Formos. Med. Assoc. 2002;101:726–728.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12517050</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fischer H., Oswald H.-P., Duba H.-C., Doczy L., Simma B., Utermann G., Haas O. Constitutional Interstitial Deletion of 17(p11.2) (Smith-Magenis Syndrome): A Clinically Recognizable Microdeletion Syndrome. Klin. Pädiatr. 1993;205:166–170. doi: 10.1055/s-2007-1025220.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-2007-1025220</ArticleId>
            <ArticleId IdType="pubmed">8350589</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Al-Qudah A.A., El-Khateeb M.S., Abu-Hamour W., Bulos N.K. Smith-Magenis Syndrome: Report of Two Cases and Review of the Literature. Ann. Saudi Med. 1994;14:417–419. doi: 10.5144/0256-4947.1994.417.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5144/0256-4947.1994.417</ArticleId>
            <ArticleId IdType="pubmed">17586958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Myers S.M., Challman T.D., Bock G.H. End-Stage Renal Failure in Smith-Magenis Syndrome. Am. J. Med. Genet. Part A. 2007;143:1922–1924. doi: 10.1002/ajmg.a.31830.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.31830</ArticleId>
            <ArticleId IdType="pubmed">17603799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fan Y.-S., Farrell S.A. Prenatal Diagnosis of Interstitial Deletion of 17(p11.2p11.2) (Smith-Magenis Syndrome) Am. J. Med. Genet. 1994;49:253–254. doi: 10.1002/ajmg.1320490220.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.1320490220</ArticleId>
            <ArticleId IdType="pubmed">8116679</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang P., Sun Y., Tian H., Rong L., Wang F., Yu X., Li Y., Gao J. Prenatal Diagnosis and Neonatal Phenotype of a de novo Microdeletion of 17p11.2p12 Associated with Smith-Magenis Syndrome and External Genital Defects. J. Genet. 2020;99:50. doi: 10.1007/s12041-020-01213-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12041-020-01213-x</ArticleId>
            <ArticleId IdType="pubmed">32661203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brendal M.A., King K.A., Zalewski C.K., Finucane B.M., Introne W., Brewer C.C., Smith A.C.M. Auditory Phenotype of Smith–Magenis Syndrome. J. Speech Lang. Hear. Res. 2017;60:1076–1087. doi: 10.1044/2016_JSLHR-H-16-0024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1044/2016_JSLHR-H-16-0024</ArticleId>
            <ArticleId IdType="pmc">PMC5548078</ArticleId>
            <ArticleId IdType="pubmed">28384694</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hidalgo de la Guía I., Garayzábal Heinze E. Diferencias Fonológicas Entre Síndromes Del Neurodesarrollo: Evidencias a Partir de Los Procesos de Simplificación Fonológica Más Frecuentes. Rev. Investig. Logop. 2019;9:81–106. doi: 10.5209/rlog.62942.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5209/rlog.62942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spilsbury J., Mohanty K. The Orthopaedic Manifestations of Smith-Magenis Syndrome. J. Pediatr. Orthop. B. 2003;12:22–26. doi: 10.1097/01.bpb.0000043565.17315.36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.bpb.0000043565.17315.36</ArticleId>
            <ArticleId IdType="pubmed">12488767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perkins T., Rosenberg J.M., Coz C.L., Alaimo J.T., Trofa M. Smith-Magenis Syndrome Patients Often Display Antibody Deficiency but Not Other Immune Pathologies. J. Allergy Clin. Immunol. Pract. 2017;5:1344–1350.e3. doi: 10.1016/j.jaip.2017.01.028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaip.2017.01.028</ArticleId>
            <ArticleId IdType="pmc">PMC5591748</ArticleId>
            <ArticleId IdType="pubmed">28286158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith A.C.M., Groptnan A.L., Bailey-Wilson J.E., Goker-Alpan O., Elsea S.H., Blancato J., Lupski J.R., Potocki L. Hypercholesterolemia in Children with Smith-Magenis Syndrome: Del (17)(p11.2p11.2) Genet. Med. 2002;4:118–125. doi: 10.1097/00125817-200205000-00004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00125817-200205000-00004</ArticleId>
            <ArticleId IdType="pubmed">12180145</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmidt L.S., Linehan W.M. Molecular Genetics and Clinical Features of Birt-Hogg-Dubé Syndrome. Nat. Rev. Urol. 2015;12:558–569. doi: 10.1038/nrurol.2015.206.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrurol.2015.206</ArticleId>
            <ArticleId IdType="pmc">PMC5119524</ArticleId>
            <ArticleId IdType="pubmed">26334087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Truong H.T., Dudding T., Blanchard C.L., Elsea S.H. Frameshift Mutation Hotspot Identified in Smith-Magenis Syndrome: Case Report and Review of Literature. BMC Med. Genet. 2010;11:142.  doi: 10.1186/1471-2350-11-142.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2350-11-142</ArticleId>
            <ArticleId IdType="pmc">PMC2964533</ArticleId>
            <ArticleId IdType="pubmed">20932317</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith A.C.M., Fleming L.R., Piskorski A.M., Amin A., Phorphutkul C., de la Monte S., Stopa E., Introne W., Vilboux T., Duncan F., et al.  Deletion of 17p11.2 Encompasses FLCN with Increased Risk of Birt-Hogg-Dubé in Smith Magenis Syndrome: Recommendation for Cancer Screening. Abstract 2603S; Proceedings of the 63rd Annual Meeting of The American Society of Human Genetics; San Diego, CA, USA. 18–22 October 2014.</Citation>
        </Reference>
        <Reference>
          <Citation>Dardour L., Verleyen P., Lesage K., Holvoet M., Devriendt K. Bilateral Renal Tumors in an Adult Man with Smith-Magenis Syndrome: The Role of the FLCN Gene. Eur. J. Med. Genet. 2016;59:499–501. doi: 10.1016/j.ejmg.2016.09.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejmg.2016.09.005</ArticleId>
            <ArticleId IdType="pubmed">27633572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finucane B., Savatt J.M., Shimelis H., Girirajan S., Myers S.M. Birt-Hogg-Dubé Symptoms in Smith-Magenis Syndrome Include Pediatric-Onset Pneumothorax. Am. J. Med. Genet. Part A. 2021;185:1922–1924. doi: 10.1002/ajmg.a.62159.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.62159</ArticleId>
            <ArticleId IdType="pubmed">33666332</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolters P.L., Gropman A.L., Martin S.C., Smith M.R., Hildenbrand H.L., Brewer C.C., Smith A.C.M. Neurodevelopment of Children Under 3 Years of Age with Smith-Magenis Syndrome. Pediatr. Neurol. 2009;41:250–258. doi: 10.1016/j.pediatrneurol.2009.04.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pediatrneurol.2009.04.015</ArticleId>
            <ArticleId IdType="pmc">PMC2785222</ArticleId>
            <ArticleId IdType="pubmed">19748044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Madduri N., Peters S.U., Voigt R.G., Llorente A.M., Lupski J.R., Potocki L. Cognitive and Adaptive Behavior Profiles in Smith-Magenis Syndrome. J. Dev. Behav. Pediatr. 2006;27:188–192. doi: 10.1097/00004703-200606000-00002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00004703-200606000-00002</ArticleId>
            <ArticleId IdType="pubmed">16775514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Udwin O., Webber C., Horn I. Abilities and Attainment in Smith-Magenis Syndrome. Dev. Med. Child Neurol. 2001;43:823. doi: 10.1017/S0012162201001499.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S0012162201001499</ArticleId>
            <ArticleId IdType="pubmed">11769269</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin S.C., Wolters P.L., Smith A.C.M. Adaptive and Maladaptive Behavior in Children with Smith-Magenis Syndrome. J. Autism Dev. Disord. 2006;36:541–552. doi: 10.1007/s10803-006-0093-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10803-006-0093-2</ArticleId>
            <ArticleId IdType="pubmed">16570214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garayzábal Heinze E., Lens Villaverde M., Moruno López E., Conde Magro T., Moura L.F., Fernández M., Sampaio A. General cognitive functioning and psycholinguistic abilities in children with Smith-Magenis Syndrome. Psicothema. 2011;23:725–731.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22047865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dykens E.M., Finucane B.M., Gayley C. Brief Report: Cognitive and Behavioral Profiles in Persons with Smith-Magenis Syndrome. J. Autism Dev. Disord. 1997;27:203–211. doi: 10.1023/A:1025800126086.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/A:1025800126086</ArticleId>
            <ArticleId IdType="pubmed">9105971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Osório A., Cruz R., Sampaio A., Garayzábal E., Carracedo Á., Fernández-Prieto M. Cognitive Functioning in Children and Adults with Smith-Magenis Syndrome. Eur. J. Med. Genet. 2012;55:394–399. doi: 10.1016/j.ejmg.2012.04.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejmg.2012.04.001</ArticleId>
            <ArticleId IdType="pubmed">22579991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poisson A., Nicolas A., Cochat P., Sanlaville D., Rigard C., De Leersnyder H., Franco P., Portes V.D., Edery P., Demily C. Behavioral Disturbance and Treatment Strategies in Smith-Magenis Syndrome. Orphanet J. Rare Dis. 2015;10:111. doi: 10.1186/s13023-015-0330-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13023-015-0330-x</ArticleId>
            <ArticleId IdType="pmc">PMC4559928</ArticleId>
            <ArticleId IdType="pubmed">26336863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Laje G., Morse R., Richter W., Ball J., Pao M., Smith A.C.M. Autism Spectrum Features in Smith-Magenis Syndrome. Am. J. Med. Genet. Part C Semin. Med. Genet. 2010;154:456–462. doi: 10.1002/ajmg.c.30275.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.c.30275</ArticleId>
            <ArticleId IdType="pmc">PMC2967410</ArticleId>
            <ArticleId IdType="pubmed">20981775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nag H.E., Nordgren A., Anderlid B.-M., Nærland T. Reversed Gender Ratio of Autism Spectrum Disorder in Smith-Magenis Syndrome. Mol. Autism. 2018;9:1. doi: 10.1186/s13229-017-0184-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13229-017-0184-2</ArticleId>
            <ArticleId IdType="pmc">PMC5759230</ArticleId>
            <ArticleId IdType="pubmed">29321841</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bissell S., Wilde L., Richards C., Moss J., Oliver C. The Behavioural Phenotype of Potocki-Lupski Syndrome: A Cross-Syndrome Comparison. J. Neurodev. Disord. 2018;10:2. doi: 10.1186/s11689-017-9221-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s11689-017-9221-x</ArticleId>
            <ArticleId IdType="pmc">PMC5795277</ArticleId>
            <ArticleId IdType="pubmed">29329513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hildenbrand H.L., Smith A.C.M. Analysis of the Sensory Profile in Children with Smith-Magenis Syndrome. Phys. Occup. Ther. Pediatr. 2012;32:48–65. doi: 10.3109/01942638.2011.572152.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/01942638.2011.572152</ArticleId>
            <ArticleId IdType="pubmed">21599572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dykens E.M., Smith A.C.M. Distinctiveness and Correlates of Maladaptive Behaviour in Children and Adolescents with Smith-Magenis Syndrome. J. Intellect. Disabil. Res. 1998;42:481–489. doi: 10.1046/j.1365-2788.1998.4260481.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-2788.1998.4260481.x</ArticleId>
            <ArticleId IdType="pubmed">10030444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finucane B., Dirrigl K.H., Simon E.W. Characterization of Self-Injurious Behaviors in Children and Adults with Smith-Magenis Syndrome. Am. J. Ment. Retard. 2001;106:52–58. doi: 10.1352/0895-8017(2001)106&lt;0052:COSIBI&gt;2.0.CO;2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1352/0895-8017(2001)106&lt;0052:COSIBI&gt;2.0.CO;2</ArticleId>
            <ArticleId IdType="pubmed">11246713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nag H.E., Nærland T. Age-Related Changes in Behavioural and Emotional Problems in Smith–Magenis Syndrome Measured with the Developmental Behavior Checklist. J. Intellect. Disabil. 2020;25:429–440. doi: 10.1177/1744629519901056.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1744629519901056</ArticleId>
            <ArticleId IdType="pmc">PMC8649468</ArticleId>
            <ArticleId IdType="pubmed">31984836</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor L., Oliver C. The Behavioural Phenotype of Smith-Magenis Syndrome: Evidence for a Gene-Environment Interaction. J. Intellect. Disabil. Res. 2008;52:830–841. doi: 10.1111/j.1365-2788.2008.01066.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2788.2008.01066.x</ArticleId>
            <ArticleId IdType="pubmed">18466291</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finucane B., Haas-Givler B. Smith-Magenis Syndrome: Genetic Basis and Clinical Implications. J. Ment. Health Res. Intellect. Disabil. 2009;2:134–148. doi: 10.1080/19315860802627619.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/19315860802627619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shayota B.J., Elsea S.H. Behavior and Sleep Disturbance in Smith-Magenis Syndrome. Curr. Opin. Psychiatry. 2019;32:73–78. doi: 10.1097/YCO.0000000000000474.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/YCO.0000000000000474</ArticleId>
            <ArticleId IdType="pmc">PMC6362978</ArticleId>
            <ArticleId IdType="pubmed">30557269</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sloneem J., Oliver C., Udwin O., Woodcock K.A. Prevalence, Phenomenology, Aetiology and Predictors of Challenging Behaviour in Smith-Magenis Syndrome. J. Intellect. Disabil. Res. 2011;55:138–151. doi: 10.1111/j.1365-2788.2010.01371.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2788.2010.01371.x</ArticleId>
            <ArticleId IdType="pubmed">21199049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alaimo J.T., Barton L.V., Mullegama S.V., Wills R.D., Foster R.H., Elsea S.H. Individuals with Smith-Magenis Syndrome Display Profound Neurodevelopmental Behavioral Deficiencies and Exhibit Food-Related Behaviors Equivalent to Prader-Willi Syndrome. Res. Dev. Disabil. 2015;47:27–38. doi: 10.1016/j.ridd.2015.08.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ridd.2015.08.011</ArticleId>
            <ArticleId IdType="pubmed">26323055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finucane B.M., Konar D., Givler B.H., Kurtt M.B., Scott C.I. The Spasmodic Upper-body Squeeze: A Chalacteristic Behavior in Smith-Magenis Syndrome. Dev. Med. Child Neurol. 1994;36:78–83. doi: 10.1111/j.1469-8749.1994.tb11770.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1469-8749.1994.tb11770.x</ArticleId>
            <ArticleId IdType="pubmed">8132119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greenberg F., Magenis W., Finucane B.M., Smith A.C.M., Patel P.I., Lupski J.R. Smith-Magenis Syndrome [del(17)(p11.2)] and Its Clinical Overlap with Prader-Willi Syndrome. Abstract; Proceedings of the 45th Annual Meeting of The American Society of Human Genetics; San Francisco, CA, USA. 24–28 October 1996.</Citation>
        </Reference>
        <Reference>
          <Citation>Smith A.C.M., Dykens E., Greenberg F. Sleep Disturbance in Smith-Magenis Syndrome (del 17 p11.2) Am. J. Med. Genet. (Neuropsychiatr. Genet.) 1998;81:186–191. doi: 10.1002/(SICI)1096-8628(19980328)81:2&lt;186::AID-AJMG11&gt;3.0.CO;2-D.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1096-8628(19980328)81:2&lt;186::AID-AJMG11&gt;3.0.CO;2-D</ArticleId>
            <ArticleId IdType="pubmed">9613860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith A.C.M., Morse R.S., Introne W., Duncan W.C. Twenty-Four-Hour Motor Activity and Body Temperature Patterns Suggest Altered Central Circadian Timekeeping in Smith–Magenis Syndrome, a Neurodevelopmental Disorder. Am. J. Med. Genet. Part A. 2019;179:224–236. doi: 10.1002/ajmg.a.61003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.61003</ArticleId>
            <ArticleId IdType="pmc">PMC6699156</ArticleId>
            <ArticleId IdType="pubmed">30690916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agar G., Brown C., Sutherland D., Coulborn S., Oliver C., Richards C. Sleep Disorders in Rare Genetic Syndromes: A Meta-Analysis of Prevalence and Profile. Mol. Autism. 2021;12:18. doi: 10.1186/s13229-021-00426-w.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13229-021-00426-w</ArticleId>
            <ArticleId IdType="pmc">PMC7908701</ArticleId>
            <ArticleId IdType="pubmed">33632309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boudreau E.A., Johnson K.P., Jackman A.R., Blancato J., Huizing M., Bendavid C., Jones M.P., Chandrasekharappa S.C., Lewy A.J., Smith A.C.M., et al.  Review of Disrupted Sleep Patterns in Smith-Magenis Syndrome and Normal Melatonin Secretion in a Patient with an Atypical Interstitial 17p11.2 Deletion. Am. J. Med. Genet. Part A. 2009;149:1382–1391. doi: 10.1002/ajmg.a.32846.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.32846</ArticleId>
            <ArticleId IdType="pmc">PMC2760428</ArticleId>
            <ArticleId IdType="pubmed">19530184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Potocki L., Glaze D., Tan D.X., Park S.S., Kashork C.D., Shaffer L.G., Reiter R.J., Lupski J.R. Circadian Rhythm Abnormalities of Melatonin in Smith-Magenis Syndrome. J. Med. Genet. 2000;37:428–433. doi: 10.1136/jmg.37.6.428.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jmg.37.6.428</ArticleId>
            <ArticleId IdType="pmc">PMC1734604</ArticleId>
            <ArticleId IdType="pubmed">10851253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goldman A.M., Potocki L., Walz K., Lynch J.K., Glaze D.G., Lupski J.R., Noebels J.L. Epilepsy and Chromosomal Rearrangements in Smith-Magenis Syndrome [del(17)(p11.2p11.2)] J. Child Neurol. 2006;21:93–98. doi: 10.1177/08830738060210021201.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/08830738060210021201</ArticleId>
            <ArticleId IdType="pubmed">16566870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boddaert N., De Leersnyder H., Bourgeois M., Munnich A., Brunelle F., Zilbovicius M. Anatomical and Functional Brain Imaging Evidence of Lenticulo-Insular Anomalies in Smith Magenis Syndrome. NeuroImage. 2004;21:1021–1025. doi: 10.1016/j.neuroimage.2003.10.040.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroimage.2003.10.040</ArticleId>
            <ArticleId IdType="pubmed">15006669</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masuno M., Asano J., Arai M., Kuwahara T., Orii T. Interstitial Deletion of 17p11.2 with Brain Abnormalities. Clin. Genet. 2008;41:278–280. doi: 10.1111/j.1399-0004.1992.tb03682.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1399-0004.1992.tb03682.x</ArticleId>
            <ArticleId IdType="pubmed">1606718</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Natacci F., Corrado L., Pierri M., Rossetti M., Zuccarini C., Riva P., Miozzo M., Larizza L. Patient with Large 17p11.2 Deletion Presenting with Smith-Magenis Syndrome and Joubert Syndrome Phenotype. Am. J. Med. Genet. 2000;95:467–472. doi: 10.1002/1096-8628(20001218)95:5&lt;467::AID-AJMG11&gt;3.0.CO;2-T.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/1096-8628(20001218)95:5&lt;467::AID-AJMG11&gt;3.0.CO;2-T</ArticleId>
            <ArticleId IdType="pubmed">11146468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Capra V., Biancheri R., Morana G., Striano P., Novara F., Ferrero G.B., Boeri L., Celle M.E., Mancardi M.M., Zuffardi O., et al.  Periventricular Nodular Heterotopia in Smith-Magenis Syndrome. Am. J. Med. Genet. Part A. 2014;164:3142–3147. doi: 10.1002/ajmg.a.36742.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.36742</ArticleId>
            <ArticleId IdType="pubmed">25257626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Girirajan S., Mendoza-Londono R., Vlangos C.N., Dupuis L., Nowak N.J., Bunyan D.J., Hatchwell E., Elsea S.H. Smith-Magenis Syndrome and Moyamoya Disease in a Patient with del(17)(p11.2p13.1) Am. J. Med. Genet. Part A. 2007;143:999–1008. doi: 10.1002/ajmg.a.31689.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.31689</ArticleId>
            <ArticleId IdType="pubmed">17431895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaudhry A.P., Schwartz C., Singh A.K. Stroke after Cardiac Surgery in a Patient with Smith-Magenis Syndrome. Tex. Heart Inst. J. 2007;34:247–249.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1894707</ArticleId>
            <ArticleId IdType="pubmed">17622381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vlangos C. Refinement of the Smith–Magenis Syndrome Critical Region to ∼950 kb and Assessment of 17p11.2 Deletions. Are All Deletions Created Equally? Mol. Genet. Metab. 2003;79:134–141. doi: 10.1016/S1096-7192(03)00048-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1096-7192(03)00048-9</ArticleId>
            <ArticleId IdType="pubmed">12809645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elsea S.H., Williams S.R. Smith-Magenis Syndrome: Haploinsufficiency of RAI1 Results in Altered Gene Regulation in Neurological and Metabolic Pathways. Expert Rev. Mol. Med. 2011;13:e14. doi: 10.1017/S1462399411001827.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S1462399411001827</ArticleId>
            <ArticleId IdType="pubmed">21545756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lupski J.R., Stankiewicz P. Genomic Disorders: Molecular Mechanisms for Rearrangements and Conveyed Phenotypes. PLoS Genet. 2005;1:e49.  doi: 10.1371/journal.pgen.0010049.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pgen.0010049</ArticleId>
            <ArticleId IdType="pmc">PMC1352149</ArticleId>
            <ArticleId IdType="pubmed">16444292</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boot E., Linders C.C., Tromp S.H., van den Boogaard M.J., van Eeghen A.M. Possible Underreporting of Pathogenic Variants in RAI1 Causing Smith–Magenis Syndrome. Am. J. Med. Genet. Part A. 2021;185:3167–3169. doi: 10.1002/ajmg.a.62380.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.62380</ArticleId>
            <ArticleId IdType="pmc">PMC8519085</ArticleId>
            <ArticleId IdType="pubmed">34089220</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Falco M., Amabile S., Acquaviva F. RAI1 Gene Mutations: Mechanisms of Smith-Magenis Syndrome. Appl. Clin. Genet. 2017;10:85–94. doi: 10.2147/TACG.S128455.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/TACG.S128455</ArticleId>
            <ArticleId IdType="pmc">PMC5680963</ArticleId>
            <ArticleId IdType="pubmed">29138588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zori R.T., Lupski J.R., Heju Z., Greenberg F., Killian J.M., Gray B.A., Driscoll D.J., Patel P.I., Zackowski J.L. Clinical, Cytogenetic, and Molecular Evidence for an Infant with Smith–Magenis Syndrome Born from a Mother Having a Mosaic 17p11.2p12 Deletion. Am. J. Med. Genet. 1993;47:504–511. doi: 10.1002/ajmg.1320470414.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.1320470414</ArticleId>
            <ArticleId IdType="pubmed">8256814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang S.P., Bidichandani S.I., Figuera L.E., Juyal R.C., Saxon P.J., Baldini A., Patel P.I. Molecular Analysis of Deletion (17)(p11.2p11.2) in a Family Segregating a 17p Paracentric Inversion: Implications for Carriers of Paracentric Inversions. Am. J. Hum. Genet. 1997;60:1184–1193.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1712444</ArticleId>
            <ArticleId IdType="pubmed">9150166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Campbell I.M., Yuan B., Robberecht C., Pfundt R., Szafranski P., McEntagart M.E., Nagamani S.C.S., Erez A., Bartnik M., Wiśniowiecka-Kowalnik B., et al.  Parental Somatic Mosaicism Is Underrecognized and Influences Recurrence Risk of Genomic Disorders. Am. J. Hum. Genet. 2014;95:173–182. doi: 10.1016/j.ajhg.2014.07.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajhg.2014.07.003</ArticleId>
            <ArticleId IdType="pmc">PMC4129404</ArticleId>
            <ArticleId IdType="pubmed">25087610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park J.P., Moeschler J.B., Davies W.S., Patel P.I., Mohandas T.K. Smith-Magenis Syndrome Resulting from a de Novo Direct Insertion of Proximal 17q into 17p11.2. Am. J. Med. Genet. 1998;77:23–27. doi: 10.1002/(SICI)1096-8628(19980428)77:1&lt;23::AID-AJMG6&gt;3.0.CO;2-M.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1096-8628(19980428)77:1&lt;23::AID-AJMG6&gt;3.0.CO;2-M</ArticleId>
            <ArticleId IdType="pubmed">9557889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goh E.S.-Y., Banwell B., Stavropoulos D.J., Shago M., Yoon G. Mosaic Microdeletion of 17p11.2-P12 and Duplication of 17q22-Q24 in a Girl with Smith-Magenis Phenotype and Peripheral Neuropathy. Am. J. Med. Genet. A. 2014;164:748–752. doi: 10.1002/ajmg.a.36322.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.36322</ArticleId>
            <ArticleId IdType="pubmed">24357149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Acquaviva F., Sana M.E., Della Monica M., Pinelli M., Postorivo D., Fontana P., Falco M.T., Nardone A.M., Lonardo F., Iascone M., et al.  First Evidence of Smith-Magenis Syndrome in Mother and Daughter Due to a Novel RAI Mutation. Am. J. Med. Genet. A. 2017;173:231–238. doi: 10.1002/ajmg.a.37989.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.37989</ArticleId>
            <ArticleId IdType="pubmed">27683195</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carmona-Mora P., Walz K. Retinoic Acid Induced 1, RAI1: A Dosage Sensitive Gene Related to Neurobehavioral Alterations Including Autistic Behavior. Curr. Genom. 2010;11:607–617. doi: 10.2174/138920210793360952.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/138920210793360952</ArticleId>
            <ArticleId IdType="pmc">PMC3078685</ArticleId>
            <ArticleId IdType="pubmed">21629438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carmona-Mora P., Encina C.A., Canales C.P., Cao L., Molina J., Kairath P., Young J.I., Walz K. Functional and Cellular Characterization of Human Retinoic Acid Induced 1 (RAI1) Mutations Associated with Smith-Magenis Syndrome. BMC Mol. Biol. 2010;11:63.  doi: 10.1186/1471-2199-11-63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2199-11-63</ArticleId>
            <ArticleId IdType="pmc">PMC2939504</ArticleId>
            <ArticleId IdType="pubmed">20738874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Darvekar S., Johnsen S.S., Eriksen A.B., Johansen T., Sjøttem E. Identification of Two Independent Nucleosome-Binding Domains in the Transcriptional Co-Activator SPBP. Biochem. J. 2012;442:65–75. doi: 10.1042/BJ20111230.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/BJ20111230</ArticleId>
            <ArticleId IdType="pubmed">22081970</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Darvekar S., Rekdal C., Johansen T., Sjøttem E. A Phylogenetic Study of SPBP and RAI1: Evolutionary Conservation of Chromatin Binding Modules. PLoS ONE. 2013;8:e78907.  doi: 10.1371/journal.pone.0078907.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0078907</ArticleId>
            <ArticleId IdType="pmc">PMC3799622</ArticleId>
            <ArticleId IdType="pubmed">24205348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang W.-H., Guenthner C.J., Xu J., Nguyen T., Schwarz L.A., Wilkinson A.W., Gozani O., Chang H.Y., Shamloo M., Luo L. Molecular and Neural Functions of Rai1, the Causal Gene for Smith-Magenis Syndrome. Neuron. 2016;92:392–406. doi: 10.1016/j.neuron.2016.09.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2016.09.019</ArticleId>
            <ArticleId IdType="pmc">PMC5098476</ArticleId>
            <ArticleId IdType="pubmed">27693255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Milne T.A., Briggs S.D., Brock H.W., Martin M.E., Gibbs D., Allis C.D., Hess J.L. MLL Targets SET Domain Methyltransferase Activity to Hox Gene Promoters. Mol. Cell. 2002;10:1107–1117. doi: 10.1016/S1097-2765(02)00741-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1097-2765(02)00741-4</ArticleId>
            <ArticleId IdType="pubmed">12453418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakamura T., Mori T., Tada S., Krajewski W., Rozovskaia T., Wassell R., Dubois G., Mazo A., Croce C.M., Canaani E. ALL-1 Is a Histone Methyltransferase That Assembles a Supercomplex of Proteins Involved in Transcriptional Regulation. Mol. Cell. 2002;10:1119–1128. doi: 10.1016/S1097-2765(02)00740-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1097-2765(02)00740-2</ArticleId>
            <ArticleId IdType="pubmed">12453419</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bi W., Saifi G.M., Shaw C.J., Walz K., Fonseca P., Wilson M., Potocki L., Lupski J.R. Mutations of RAI1, a PHD-Containing Protein, in Nondeletion Patients with Smith-Magenis Syndrome. Hum. Genet. 2004;115:515–524. doi: 10.1007/s00439-004-1187-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00439-004-1187-6</ArticleId>
            <ArticleId IdType="pubmed">15565467</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garay P.M., Chen A., Tsukahara T., Rodríguez Díaz J.C., Kohen R., Althaus J.C., Wallner M.A., Giger R.J., Jones K.S., Sutton M.A., et al.  RAI1 Regulates Activity-Dependent Nascent Transcription and Synaptic Scaling. Cell Rep. 2020;32:108002. doi: 10.1016/j.celrep.2020.108002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2020.108002</ArticleId>
            <ArticleId IdType="pmc">PMC7418709</ArticleId>
            <ArticleId IdType="pubmed">32783930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams S.R., Zies D., Mullegama S.V., Grotewiel M.S., Elsea S.H. Smith-Magenis Syndrome Results in Disruption of CLOCK Gene Transcription and Reveals an Integral Role for RAI1 in the Maintenance of Circadian Rhythmicity. Am. J. Hum. Genet. 2012;90:941–949. doi: 10.1016/j.ajhg.2012.04.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajhg.2012.04.013</ArticleId>
            <ArticleId IdType="pmc">PMC3370274</ArticleId>
            <ArticleId IdType="pubmed">22578325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garay P.M., Wallner M.A., Iwase S. Yin–Yang Actions of Histone Methylation Regulatory Complexes in the Brain. Epigenomics. 2016;8:1689–1708. doi: 10.2217/epi-2016-0090.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2217/epi-2016-0090</ArticleId>
            <ArticleId IdType="pmc">PMC5289040</ArticleId>
            <ArticleId IdType="pubmed">27855486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eberl H.C., Spruijt C.G., Kelstrup C.D., Vermeulen M., Mann M. A Map of General and Specialized Chromatin Readers in Mouse Tissues Generated by Label-Free Interaction Proteomics. Mol. Cell. 2013;49:368–378. doi: 10.1016/j.molcel.2012.10.026.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molcel.2012.10.026</ArticleId>
            <ArticleId IdType="pubmed">23201125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones W.D., Dafou D., McEntagart M., Woollard W.J., Elmslie F.V., Holder-Espinasse M., Irving M., Saggar A.K., Smithson S., Trembath R.C., et al.  De Novo Mutations in MLL Cause Wiedemann-Steiner Syndrome. Am. J. Hum. Genet. 2012;91:358–364. doi: 10.1016/j.ajhg.2012.06.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajhg.2012.06.008</ArticleId>
            <ArticleId IdType="pmc">PMC3415539</ArticleId>
            <ArticleId IdType="pubmed">22795537</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Babbs C., Lloyd D., Pagnamenta A.T., Twigg S.R.F., Green J., McGowan S.J., Mirza G., Naples R., Sharma V.P., Volpi E.V., et al.  De Novo and Rare Inherited Mutations Implicate the Transcriptional Coregulator TCF20/SPBP in Autism Spectrum Disorder. J. Med. Genet. 2014;51:737–747. doi: 10.1136/jmedgenet-2014-102582.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jmedgenet-2014-102582</ArticleId>
            <ArticleId IdType="pmc">PMC4215269</ArticleId>
            <ArticleId IdType="pubmed">25228304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams S.R., Aldred M.A., Der Kaloustian V.M., Halal F., Gowans G., McLeod D.R., Zondag S., Toriello H.V., Magenis R.E., Elsea S.H. Haploinsufficiency of HDAC4 Causes Brachydactyly Mental Retardation Syndrome, with Brachydactyly Type E, Developmental Delays, and Behavioral Problems. Am. J. Hum. Genet. 2010;87:219–228. doi: 10.1016/j.ajhg.2010.07.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajhg.2010.07.011</ArticleId>
            <ArticleId IdType="pmc">PMC2917703</ArticleId>
            <ArticleId IdType="pubmed">20691407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams S.R., Mullegama S.V., Rosenfeld J.A., Dagli A.I., Hatchwell E., Allen W.P., Williams C.A., Elsea S.H. Haploinsufficiency of MBD5 Associated with a Syndrome Involving Microcephaly, Intellectual Disabilities, Severe Speech Impairment, and Seizures. Eur. J. Hum. Genet. 2010;18:436–441. doi: 10.1038/ejhg.2009.199.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ejhg.2009.199</ArticleId>
            <ArticleId IdType="pmc">PMC2987257</ArticleId>
            <ArticleId IdType="pubmed">19904302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Talkowski M.E., Mullegama S.V., Rosenfeld J.A., van Bon B.W.M., Shen Y., Repnikova E.A., Gastier-Foster J., Thrush D.L., Kathiresan S., Ruderfer D.M., et al.  Assessment of 2q23.1 Microdeletion Syndrome Implicates MBD5 as a Single Causal Locus of Intellectual Disability, Epilepsy, and Autism Spectrum Disorder. Am. J. Hum. Genet. 2011;89:551–563. doi: 10.1016/j.ajhg.2011.09.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajhg.2011.09.011</ArticleId>
            <ArticleId IdType="pmc">PMC3188839</ArticleId>
            <ArticleId IdType="pubmed">21981781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mullegama S.V., Alaimo J.T., Chen L., Elsea S.H. Phenotypic and Molecular Convergence of 2q23.1 Deletion Syndrome with Other Neurodevelopmental Syndromes Associated with Autism Spectrum Disorder. Int. J. Mol. Sci. 2015;16:7627–7643. doi: 10.3390/ijms16047627.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms16047627</ArticleId>
            <ArticleId IdType="pmc">PMC4425039</ArticleId>
            <ArticleId IdType="pubmed">25853262</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mullegama S.V., Pugliesi L., Burns B., Shah Z., Tahir R., Gu Y., Nelson D.L., Elsea S.H. MBD5 Haploinsufficiency Is Associated with Sleep Disturbance and Disrupts Circadian Pathways Common to Smith-Magenis and Fragile X Syndromes. Eur. J. Hum. Genet. 2015;23:781–789. doi: 10.1038/ejhg.2014.200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ejhg.2014.200</ArticleId>
            <ArticleId IdType="pmc">PMC4795052</ArticleId>
            <ArticleId IdType="pubmed">25271084</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kleefstra T., Kramer J.M., Neveling K., Willemsen M.H., Koemans T.S., Vissers L.E.L.M., Wissink-Lindhout W., Fenckova M., van den Akker W.M.R., Kasri N.N., et al.  Disruption of an EHMT1-Associated Chromatin-Modification Module Causes Intellectual Disability. Am. J. Hum. Genet. 2012;91:73–82. doi: 10.1016/j.ajhg.2012.05.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajhg.2012.05.003</ArticleId>
            <ArticleId IdType="pmc">PMC3397275</ArticleId>
            <ArticleId IdType="pubmed">22726846</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koemans T.S., Kleefstra T., Chubak M.C., Stone M.H., Reijnders M.R.F., de Munnik S., Willemsen M.H., Fenckova M., Stumpel C.T.R.M., Bok L.A., et al.  Functional Convergence of Histone Methyltransferases EHMT1 and KMT2C Involved in Intellectual Disability and Autism Spectrum Disorder. PLoS Genet. 2017;13:e1006864.  doi: 10.1371/journal.pgen.1006864.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pgen.1006864</ArticleId>
            <ArticleId IdType="pmc">PMC5656305</ArticleId>
            <ArticleId IdType="pubmed">29069077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kleefstra T., Brunner H.G., Amiel J., Oudakker A.R., Nillesen W.M., Magee A., Geneviève D., Cormier-Daire V., van Esch H., Fryns J.-P., et al.  Loss-of-Function Mutations in Euchromatin Histone Methyl Transferase 1 (EHMT1) Cause the 9q34 Subtelomeric Deletion Syndrome. Am. J. Hum. Genet. 2006;79:370–377. doi: 10.1086/505693.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/505693</ArticleId>
            <ArticleId IdType="pmc">PMC1559478</ArticleId>
            <ArticleId IdType="pubmed">16826528</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Benevento M., Iacono G., Selten M., Ba W., Oudakker A., Frega M., Keller J., Mancini R., Lewerissa E., Kleefstra T., et al.  Histone Methylation by the Kleefstra Syndrome Protein EHMT1 Mediates Homeostatic Synaptic Scaling. Neuron. 2016;91:341–355. doi: 10.1016/j.neuron.2016.06.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2016.06.003</ArticleId>
            <ArticleId IdType="pubmed">27373831</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iacono G., Dubos A., Méziane H., Benevento M., Habibi E., Mandoli A., Riet F., Selloum M., Feil R., Zhou H., et al.  Increased H3K9 Methylation and Impaired Expression of Protocadherins Are Associated with the Cognitive Dysfunctions of the Kleefstra Syndrome. Nucleic Acids Res. 2018;46:4950–4965. doi: 10.1093/nar/gky196.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gky196</ArticleId>
            <ArticleId IdType="pmc">PMC6007260</ArticleId>
            <ArticleId IdType="pubmed">29554304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Loviglio M.N., Beck C.R., White J.J., Leleu M., Harel T., Guex N., Niknejad A., Bi W., Chen E.S., Crespo I., et al.  Identification of a RAI1-Associated Disease Network through Integration of Exome Sequencing, Transcriptomics, and 3D Genomics. Genome Med. 2016;8:105. doi: 10.1186/s13073-016-0359-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13073-016-0359-z</ArticleId>
            <ArticleId IdType="pmc">PMC5088687</ArticleId>
            <ArticleId IdType="pubmed">27799067</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berger S.I., Ciccone C., Simon K.L., Malicdan M.C., Vilboux T., Billington C., Fischer R., Introne W.J., Gropman A., Blancato J.K., et al.  Exome Analysis of Smith–Magenis-like Syndrome Cohort Identifies de novo Likely Pathogenic Variants. Hum. Genet. 2017;136:409–420. doi: 10.1007/s00439-017-1767-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00439-017-1767-x</ArticleId>
            <ArticleId IdType="pmc">PMC5848494</ArticleId>
            <ArticleId IdType="pubmed">28213671</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vetrini F., McKee S., Rosenfeld J.A., Suri M., Lewis A.M., Nugent K.M., Roeder E., Littlejohn R.O., Holder S., Zhu W., et al.  De Novo and Inherited TCF20 Pathogenic Variants Are Associated with Intellectual Disability, Dysmorphic Features, Hypotonia, and Neurological Impairments with Similarities to Smith-Magenis Syndrome. Genome Med. 2019;11:12. doi: 10.1186/s13073-019-0623-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13073-019-0623-0</ArticleId>
            <ArticleId IdType="pmc">PMC6393995</ArticleId>
            <ArticleId IdType="pubmed">30819258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kerkhof J., Squeo G.M., McConkey H., Levy M.A., Piemontese M.R., Castori M., Accadia M., Biamino E., Della Monica M., Di Giacomo M.C., et al.  DNA Methylation Episignature Testing Improves Molecular Diagnosis of Mendelian Chromatinopathies. Genet. Med. 2022;24:51–60. doi: 10.1016/j.gim.2021.08.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.gim.2021.08.007</ArticleId>
            <ArticleId IdType="pubmed">34906459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aref-Eshghi E., Kerkhof J., Pedro V.P., Barat-Houari M., Ruiz-Pallares N., Andrau J.-C., Lacombe D., Van-Gils J., Fergelot P., Dubourg C., et al.  Evaluation of DNA Methylation Episignatures for Diagnosis and Phenotype Correlations in 42 Mendelian Neurodevelopmental Disorders. Am. J. Hum. Genet. 2020;106:356–370. doi: 10.1016/j.ajhg.2020.01.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajhg.2020.01.019</ArticleId>
            <ArticleId IdType="pmc">PMC7058829</ArticleId>
            <ArticleId IdType="pubmed">32109418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Laje G., Bernert R., Morse R., Pao M., Smith A.C.M. Pharmacological Treatment of Disruptive Behavior in Smith-Magenis Syndrome. Am. J. Med. Genet. Part C Semin. Med. Genet. 2010;154:463–468. doi: 10.1002/ajmg.c.30282.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.c.30282</ArticleId>
            <ArticleId IdType="pmc">PMC3022344</ArticleId>
            <ArticleId IdType="pubmed">20981776</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Müller A.R., Zinkstok J.R., Rommelse N.N.J., van de Ven P.M., Roes K.C.B., Wijburg F.A., de Rooij-Askes E., Linders C., Boot E., van Eeghen A.M. Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Patients with Smith–Magenis Syndrome: Protocol for a Series of N-of-1 Trials. Orphanet J. Rare Dis. 2021;16:380. doi: 10.1186/s13023-021-02003-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13023-021-02003-z</ArticleId>
            <ArticleId IdType="pmc">PMC8424817</ArticleId>
            <ArticleId IdType="pubmed">34496899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hagerman R.J. Psychopharmacological Interventions in Fragile X Syndrome, Fetal Alcohol Syndrome, Prader-Willi Syndrome, Angelman Syndrome, Smith-Magenis Syndrome, and Velocardiofacial Syndrome. Ment. Retard. Dev. Disabil. Res. Rev. 1999;5:305–313. doi: 10.1002/(SICI)1098-2779(1999)5:4&lt;305::AID-MRDD8&gt;3.0.CO;2-L.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1098-2779(1999)5:4&lt;305::AID-MRDD8&gt;3.0.CO;2-L</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Niederhofer H. Efficacy of Risperidone Treatment in Smith-Magenis Syndrome (del 17 pll. 2) Psychiatr. Danub. 2007;19:189–192.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17914318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaplan K.A., Elsea S.H., Potocki L. Management of Sleep Disturbances Associated with Smith-Magenis Syndrome. CNS Drugs. 2020;34:723–730. doi: 10.1007/s40263-020-00733-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s40263-020-00733-5</ArticleId>
            <ArticleId IdType="pubmed">32495322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams Buckley A., Hirtz D., Oskoui M., Armstrong M.J., Batra A., Bridgemohan C., Coury D., Dawson G., Donley D., Findling R.L., et al.  Practice Guideline: Treatment for Insomnia and Disrupted Sleep Behavior in Children and Adolescents with Autism Spectrum Disorder. Neurology. 2020;94:392–404. doi: 10.1212/WNL.0000000000009033.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000009033</ArticleId>
            <ArticleId IdType="pmc">PMC7238942</ArticleId>
            <ArticleId IdType="pubmed">32051244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Leersnyder H., Bresson J.L., de Blois M.-C., Souberbielle J.-C., Mogenet A., Delhotal-Landes B., Salefranque F., Munnich A. Beta 1-Adrenergic Antagonists and Melatonin Reset the Clock and Restore Sleep in a Circadian Disorder, Smith-Magenis Syndrome. J. Med. Genet. 2003;40:74–78. doi: 10.1136/jmg.40.1.74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jmg.40.1.74</ArticleId>
            <ArticleId IdType="pmc">PMC1735264</ArticleId>
            <ArticleId IdType="pubmed">12525548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Polymeropoulos C.M., Brooks J., Czeisler E.L., Fisher M.A., Gibson M.M., Kite K., Smieszek S.P., Xiao C., Elsea S.H., Birznieks G., et al.  Tasimelteon Safely and Effectively Improves Sleep in Smith-Magenis Syndrome: A Double-Blind Randomized Trial Followed by an Open-Label Extension. Genet. Med. 2021;23:2426–2432. doi: 10.1038/s41436-021-01282-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41436-021-01282-y</ArticleId>
            <ArticleId IdType="pmc">PMC8629754</ArticleId>
            <ArticleId IdType="pubmed">34316024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richardson G.S., Zee P.C., Wang-Weigand S., Rodriguez L., Peng X. Circadian Phase-Shifting Effects of Repeated Ramelteon Administration in Healthy Adults. J. Clin. Sleep Med. 2008;4:456–461. doi: 10.5664/jcsm.27282.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5664/jcsm.27282</ArticleId>
            <ArticleId IdType="pmc">PMC2576313</ArticleId>
            <ArticleId IdType="pubmed">18853704</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35205380</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>20</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2073-4425</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>13</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Feb</Month>
              <Day>11</Day>
            </PubDate>
          </JournalIssue>
          <Title>Genes</Title>
          <ISOAbbreviation>Genes (Basel)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Smith-Magenis Syndrome-Clinical Review, Biological Background and Related Disorders.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">335</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/genes13020335</ELocationID>
        <Abstract>
          <AbstractText>Smith-Magenis syndrome (SMS) is a complex genetic disorder characterized by distinctive physical features, developmental delay, cognitive impairment, and a typical behavioral phenotype. SMS is caused by interstitial 17p11.2 deletions (90%), encompassing multiple genes and including the retinoic acid-induced 1 gene (<i>RAI1</i>), or by pathogenic variants in <i>RAI1</i> itself (10%). <i>RAI1</i> is a dosage-sensitive gene expressed in many tissues and acting as transcriptional regulator. The majority of individuals exhibit a mild-to-moderate range of intellectual disability. The behavioral phenotype includes significant sleep disturbance, stereotypes, maladaptive and self-injurious behaviors. In this review, we summarize current clinical knowledge and therapeutic approaches. We further discuss the common biological background shared with other conditions commonly retained in differential diagnosis.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rinaldi</LastName>
            <ForeName>Berardo</ForeName>
            <Initials>B</Initials>
            <Identifier Source="ORCID">0000-0001-5763-5347</Identifier>
            <AffiliationInfo>
              <Affiliation>Clinical Genetics Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Villa</LastName>
            <ForeName>Roberta</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Genetics Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sironi</LastName>
            <ForeName>Alessandra</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-3997-8810</Identifier>
            <AffiliationInfo>
              <Affiliation>Experimental Research Laboratory of Medical Cytogenetics and Molecular Genetics, Istituto Auxologico Italiano, IRCCS, 20145 Milan, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Segrate, 20090 Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Garavelli</LastName>
            <ForeName>Livia</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Genetics Unit, Azienda USL-IRCCS of Reggio Emilia, 42123 Reggio Emilia, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Finelli</LastName>
            <ForeName>Palma</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0001-8464-6906</Identifier>
            <AffiliationInfo>
              <Affiliation>Experimental Research Laboratory of Medical Cytogenetics and Molecular Genetics, Istituto Auxologico Italiano, IRCCS, 20145 Milan, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Segrate, 20090 Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bedeschi</LastName>
            <ForeName>Maria Francesca</ForeName>
            <Initials>MF</Initials>
            <Identifier Source="ORCID">0000-0002-6723-9177</Identifier>
            <AffiliationInfo>
              <Affiliation>Clinical Genetics Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Genes (Basel)</MedlineTA>
        <NlmUniqueID>101551097</NlmUniqueID>
        <ISSNLinking>2073-4425</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D015534">Trans-Activators</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008607" MajorTopicYN="Y">Intellectual Disability</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058496" MajorTopicYN="Y">Smith-Magenis Syndrome</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015534" MajorTopicYN="N">Trans-Activators</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">17p11.2 deletion syndrome</Keyword>
        <Keyword MajorTopicYN="Y">RAI1</Keyword>
        <Keyword MajorTopicYN="Y">SMS</Keyword>
        <Keyword MajorTopicYN="Y">Smith-Magenis</Keyword>
        <Keyword MajorTopicYN="Y">sleep disorders</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>25</Day>
          <Hour>1</Hour>
          <Minute>6</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35205380</ArticleId>
        <ArticleId IdType="pmc">PMC8872351</ArticleId>
        <ArticleId IdType="doi">10.3390/genes13020335</ArticleId>
        <ArticleId IdType="pii">genes13020335</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Allanson J.E., Greenberg F., Smith A.C.M. The Face of Smith-Magenis Syndrome: A Subjective and Objective Study. J. Med. Genet. 1999;36:394–397. doi: 10.1136/jmg.36.5.394.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jmg.36.5.394</ArticleId>
            <ArticleId IdType="pmc">PMC1734375</ArticleId>
            <ArticleId IdType="pubmed">10353786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith A.C.M., McGavran L., Robinson J., Waldstein G., Macfarlane J., Zonona J., Reiss J., Lahr M., Allen L., Magenis E. Interstitial Deletion of (17)(p11.2p11.2) in Nine Patients. Am. J. Med. Genet. 1986;24:393–414. doi: 10.1002/ajmg.1320240303.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.1320240303</ArticleId>
            <ArticleId IdType="pubmed">2425619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greenberg F., Guzzetta V., De Oca-Luna R.M., Magenis R.E., Smith A.C.M., Richter S.F., Kondo I., Dobyns W.B., Patel P.I., Lupski J.R. Molecular Analysis of the Smith-Magenis Syndrome: A Possible Contiguous-Gene Syndrome Associated with del(17)(p11.2) Am. J. Hum. Genet. 1991;49:1207–1218.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1686451</ArticleId>
            <ArticleId IdType="pubmed">1746552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith A.C.M., McGavran L., Waldstein G. Deletion of the 17 Short Arm in Two Patients with Facial Clefts. Am. J. Med. Genet. 1982;34:410A.</Citation>
        </Reference>
        <Reference>
          <Citation>Slager R.E., Newton T.L., Vlangos C.N., Finucane B., Elsea S.H. Mutations in RAI1 Associated with Smith-Magenis Syndrome. Nat. Genet. 2003;33:466–468. doi: 10.1038/ng1126.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng1126</ArticleId>
            <ArticleId IdType="pubmed">12652298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith A.C.M., Boyd K.E., Brennan C., Charles J., Elsea S.H., Finucane B.M., Foster R., Gropman A., Girirajan S., Haas-Givler B. Smith-Magenis Syndrome.  [(accessed on 9 December 2021)];GeneReviews® [Internet]  Available online:  https://www.ncbi.nlm.nih.gov/books/NBK1310/</Citation>
        </Reference>
        <Reference>
          <Citation>Smith A.C.M., Magenis R.E., Elsea S.H. Overview of Smith-Magenis Syndrome. J. Assoc. Genet. Technol. 2005;31:163–167.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16354942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edelman E.A., Girirajan S., Finucane B., Patel P.I., Lupski J.R., Smith A.C.M., Elsea S.H. Gender, Genotype, and Phenotype Differences in Smith-Magenis Syndrome: A Meta-Analysis of 105 Cases. Clin. Genet. 2007;71:540–550. doi: 10.1111/j.1399-0004.2007.00815.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1399-0004.2007.00815.x</ArticleId>
            <ArticleId IdType="pubmed">17539903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greenberg F., Lewis R.A., Potocki L., Glaze D., Parke J., Killian J., Murphy M.A., Williamson D., Brown F., Dutton R., et al.  Multi-Disciplinary Clinical Study of Smith-Magenis Syndrome (Deletion 17p11.2) Am. J. Med. Genet. 1996;62:247–254. doi: 10.1002/(SICI)1096-8628(19960329)62:3&lt;247::AID-AJMG9&gt;3.0.CO;2-Q.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1096-8628(19960329)62:3&lt;247::AID-AJMG9&gt;3.0.CO;2-Q</ArticleId>
            <ArticleId IdType="pubmed">8882782</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elsea S.H., Girirajan S.S. Smith-Magenis Syndrome. Eur. J. Hum. Genet. 2008;16:412–421. doi: 10.1038/sj.ejhg.5202009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.ejhg.5202009</ArticleId>
            <ArticleId IdType="pubmed">18231123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Girirajan S., Elsas L.J., Devriendt K., Elsea S.H. RAI1 Variations in Smith-Magenis Syndrome Patients without 17p11.2 Deletions. J. Med. Genet. 2005;42:820–828. doi: 10.1136/jmg.2005.031211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jmg.2005.031211</ArticleId>
            <ArticleId IdType="pmc">PMC1735950</ArticleId>
            <ArticleId IdType="pubmed">15788730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guérin-Moreau M., Colin E., Nguyen S., Andrieux J., De Leersnyder H., Bonneau D., Martin L. Dermatologic Features of Smith-Magenis Syndrome. Pediatr. Dermatol. 2015;32:337–341. doi: 10.1111/pde.12517.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/pde.12517</ArticleId>
            <ArticleId IdType="pubmed">25684097</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen R.M., Lupski J.R., Greenberg F., Lewis R.A. Ophthalmic Manifestations of Smith-Magenis Syndrome. Ophthalmology. 1996;103:1084–1091. doi: 10.1016/S0161-6420(96)30563-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0161-6420(96)30563-0</ArticleId>
            <ArticleId IdType="pubmed">8684798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finucane B.M., Jaeger E.R., Kurtz M.B., Weinstein M., Scott C.I. Eye Abnormalities in the Smith-Magenis Contiguous Gene Deletion Syndrome. Am. J. Med. Genet. 1993;45:443–446. doi: 10.1002/ajmg.1320450409.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.1320450409</ArticleId>
            <ArticleId IdType="pubmed">8465847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gropman A.L., Duncan W.C., Smith A.C.M. Neurologic and Developmental Features of the Smith-Magenis Syndrome (del 17p11.2) Pediatr. Neurol. 2006;34:337–350. doi: 10.1016/j.pediatrneurol.2005.08.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pediatrneurol.2005.08.018</ArticleId>
            <ArticleId IdType="pubmed">16647992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen K.S., Potocki L., Lupski J.R. The Smith-Magenis Syndrome [del(17)p11.2]: Clinical Review and Molecular Advances. Ment. Retard. Dev. Disabil. Res. Rev. 1996;2:122–129. doi: 10.1002/(SICI)1098-2779(1996)2:3&lt;122::AID-MRDD2&gt;3.0.CO;2-U.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1098-2779(1996)2:3&lt;122::AID-MRDD2&gt;3.0.CO;2-U</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tomona N., Smith A.C.M., Guadagnini J.P., Hart T.C. Craniofacial and Dental Phenotype of Smith-Magenis Syndrome. Am. J. Med. Genet. Part A. 2006;140:2556–2561. doi: 10.1002/ajmg.a.31371.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.31371</ArticleId>
            <ArticleId IdType="pubmed">17001665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Di Cicco M., Padoan R., Felisati G., Dilani D., Moretti E., Guerneri S., Selicorni A. Otorhinolaringologic Manifestation of Smith-Magenis Syndrome. Int. J. Pediatr. Otorhinolaryngol. 2001;59:147–150. doi: 10.1016/S0165-5876(01)00475-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0165-5876(01)00475-X</ArticleId>
            <ArticleId IdType="pubmed">11378192</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith A.C.M., Dykens E., Greenberg F. Behavioral Phenotype of Smith-Magenis Syndrome (del 17p11.2) Am. J. Med. Genet. Neuropsychiatr. Genet. 1998;81:179–185. doi: 10.1002/(SICI)1096-8628(19980328)81:2&lt;179::AID-AJMG10&gt;3.0.CO;2-E.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1096-8628(19980328)81:2&lt;179::AID-AJMG10&gt;3.0.CO;2-E</ArticleId>
            <ArticleId IdType="pubmed">9613859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>La Guía I.H.D., Garayzábal-Heinze E., Gómez-Vilda P. Voice Characteristics in Smith–Magenis Syndrome: An Acoustic Study of Laryngeal Biomechanics. Languages. 2020;5:31.  doi: 10.3390/languages5030031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/languages5030031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Girirajan S., Vlangos C.N., Szomju B.B., Edelman E., Trevors C.D., Dupuis L., Nezarati M., Bunyan D.J., Elsea S.H. Genotype-Phenotype Correlation in Smith-Magenis Syndrome: Evidence That Multiple Genes in 17p11.2 Contribute to the Clinical Spectrum. Genet. Med. 2006;8:417–427. doi: 10.1097/01.gim.0000228215.32110.89.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.gim.0000228215.32110.89</ArticleId>
            <ArticleId IdType="pubmed">16845274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kondo I., Matsuura S., Kuwajima K., Tokashiki M., Izumikawa Y., Naritomi K., Niikawa N., Kajii T. Diagnostic Hand Anomalies in Smith-Magenis Syndrome: Four New Patients with del (17)(p11.2p11.2) Am. J. Med. Genet. 1991;41:225–229. doi: 10.1002/ajmg.1320410219.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.1320410219</ArticleId>
            <ArticleId IdType="pubmed">1785639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schlesinger A.E., Potocki L., Poznanski A.K., Lupski J.R. The Hand in Smith-Magenis Syndrome (Deletion 17p11.2): Evaluation by Metacarpophalangeal Pattern Profile Analysis. Pediatr. Radiol. 2003;33:173–176. doi: 10.1007/s00247-002-0826-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00247-002-0826-0</ArticleId>
            <ArticleId IdType="pubmed">12612815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>MarianneJensen L., Kirchhoff M. Polydactyly in a Boy with Smith-Magenis Syndrome. Clin. Dysmorphol. 2005;14:189–190. doi: 10.1097/00019605-200510000-00004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00019605-200510000-00004</ArticleId>
            <ArticleId IdType="pubmed">16155420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rive Le Gouard N., Jacquinet A., Ruaud L., Deleersnyder H., Ageorges F., Gallard J., Lacombe D., Odent S., Mikaty M., Manouvrier-Hanu S., et al.  Smith-Magenis Syndrome: Clinical and Behavioral Characteristics in a Large Retrospective Cohort. Clin. Genet. 2021;99:519–528. doi: 10.1111/cge.13906.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cge.13906</ArticleId>
            <ArticleId IdType="pubmed">33368193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crain C.A.  Master’s Thesis. University of Texas Graduate School of Biomedical Sciences; Houston, TX, USA: May, 2010. An Assessment of Obesity and Hyperphagia in Individuals with Smith-Magenis Syndrome.</Citation>
        </Reference>
        <Reference>
          <Citation>Burns B., Schmidt K., Williams S.R., Kim S., Girirajan S., Elsea S.H. RAI1 Haploinsufficiency Causes Reduced Bdnf Expression Resulting in Hyperphagia, Obesity and Altered Fat Distribution in Mice and Humans with No Evidence of Metabolic Syndrome. Hum. Mol. Genet. 2010;19:4026–4042. doi: 10.1093/hmg/ddq317.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddq317</ArticleId>
            <ArticleId IdType="pmc">PMC7714048</ArticleId>
            <ArticleId IdType="pubmed">20663924</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Potocki L., Shaw C.J., Stankiewicz P., Lupski J.R. Variability in Clinical Phenotype despite Common Chromosomal Deletion in Smith-Magenis Syndrome [del(17)(p11.2p11.2)] Genet. Med. 2003;5:430–434. doi: 10.1097/01.GIM.0000095625.14160.AB.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.GIM.0000095625.14160.AB</ArticleId>
            <ArticleId IdType="pubmed">14614393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith A.C.M., Gropman A.L.  Cassidy and Allanson’s Management of Genetic Syndromes. John Wiley &amp; Sons, Inc.; Hoboken, NJ, USA: 2021. Smith-Magenis Syndrome; pp. 863–893.</Citation>
        </Reference>
        <Reference>
          <Citation>De Leersnyder H., De Blois M.C., Claustrat B., Romana S., Albrecht U., Von Kleist-Retzow J.C., Delobel B., Viot G., Lyonnet S., Vekemans M., et al.  Inversion of the Circadian Rhythm of Melatonin in the Smith-Magenis Syndrome. J. Pediatr. 2001;139:111–116. doi: 10.1067/mpd.2001.115018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1067/mpd.2001.115018</ArticleId>
            <ArticleId IdType="pubmed">11445803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Itoh M., Hayashi M., Hasegawa T., Shimohira M., Kohyama J. Systemic Growth Hormone Corrects Sleep Disturbance in Smith-Magenis Syndrome. Brain Dev. 2004;26:484–486. doi: 10.1016/j.braindev.2004.01.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.braindev.2004.01.007</ArticleId>
            <ArticleId IdType="pubmed">15351087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spadoni E., Colapietro P., Bozzola M., Marseglia G.L., Repossi L., Danesino C., Larizza L., Maraschio P. Smith-Magenis Syndrome and Growth Hormone Deficiency. Eur. J. Pediatr. 2004;163:353–358. doi: 10.1007/s00431-004-1460-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00431-004-1460-7</ArticleId>
            <ArticleId IdType="pubmed">15138811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stratton R.F., Dobyns W.B., Greenberg F., DeSana J.B., Moore C., Fidone G., Runge G.H., Feldman P., Sekhon G.S., Pauli R.M. Interstitial Deletion of (17)(p11.2p11.2): Report of Six Additional Patients with a New Chromosome Deletion Syndrome. Am. J. Med. Genet. 1986;24:421–432. doi: 10.1002/ajmg.1320240305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.1320240305</ArticleId>
            <ArticleId IdType="pubmed">3728561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Onesimo R., Versacci P., Delogu A.B., De Rosa G., Pugnaloni F., Blandino R., Leoni C., Calcagni G., Digilio M.C., Zollino M., et al.  Smith–Magenis Syndrome: Report of Morphological and New Functional Cardiac Findings with Review of the Literature. Am. J. Med. Genet. Part A. 2021;185:2003–2011. doi: 10.1002/ajmg.a.62196.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.62196</ArticleId>
            <ArticleId IdType="pubmed">33811726</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chou I.C., Tsai F.J., Yu M.T., Tsai C.H. Smith-Magenis Syndrome with Bilateral Vesicoureteral Reflux: A Case Report. J. Formos. Med. Assoc. 2002;101:726–728.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12517050</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fischer H., Oswald H.-P., Duba H.-C., Doczy L., Simma B., Utermann G., Haas O. Constitutional Interstitial Deletion of 17(p11.2) (Smith-Magenis Syndrome): A Clinically Recognizable Microdeletion Syndrome. Klin. Pädiatr. 1993;205:166–170. doi: 10.1055/s-2007-1025220.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-2007-1025220</ArticleId>
            <ArticleId IdType="pubmed">8350589</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Al-Qudah A.A., El-Khateeb M.S., Abu-Hamour W., Bulos N.K. Smith-Magenis Syndrome: Report of Two Cases and Review of the Literature. Ann. Saudi Med. 1994;14:417–419. doi: 10.5144/0256-4947.1994.417.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5144/0256-4947.1994.417</ArticleId>
            <ArticleId IdType="pubmed">17586958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Myers S.M., Challman T.D., Bock G.H. End-Stage Renal Failure in Smith-Magenis Syndrome. Am. J. Med. Genet. Part A. 2007;143:1922–1924. doi: 10.1002/ajmg.a.31830.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.31830</ArticleId>
            <ArticleId IdType="pubmed">17603799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fan Y.-S., Farrell S.A. Prenatal Diagnosis of Interstitial Deletion of 17(p11.2p11.2) (Smith-Magenis Syndrome) Am. J. Med. Genet. 1994;49:253–254. doi: 10.1002/ajmg.1320490220.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.1320490220</ArticleId>
            <ArticleId IdType="pubmed">8116679</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang P., Sun Y., Tian H., Rong L., Wang F., Yu X., Li Y., Gao J. Prenatal Diagnosis and Neonatal Phenotype of a de novo Microdeletion of 17p11.2p12 Associated with Smith-Magenis Syndrome and External Genital Defects. J. Genet. 2020;99:50. doi: 10.1007/s12041-020-01213-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12041-020-01213-x</ArticleId>
            <ArticleId IdType="pubmed">32661203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brendal M.A., King K.A., Zalewski C.K., Finucane B.M., Introne W., Brewer C.C., Smith A.C.M. Auditory Phenotype of Smith–Magenis Syndrome. J. Speech Lang. Hear. Res. 2017;60:1076–1087. doi: 10.1044/2016_JSLHR-H-16-0024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1044/2016_JSLHR-H-16-0024</ArticleId>
            <ArticleId IdType="pmc">PMC5548078</ArticleId>
            <ArticleId IdType="pubmed">28384694</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hidalgo de la Guía I., Garayzábal Heinze E. Diferencias Fonológicas Entre Síndromes Del Neurodesarrollo: Evidencias a Partir de Los Procesos de Simplificación Fonológica Más Frecuentes. Rev. Investig. Logop. 2019;9:81–106. doi: 10.5209/rlog.62942.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5209/rlog.62942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spilsbury J., Mohanty K. The Orthopaedic Manifestations of Smith-Magenis Syndrome. J. Pediatr. Orthop. B. 2003;12:22–26. doi: 10.1097/01.bpb.0000043565.17315.36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.bpb.0000043565.17315.36</ArticleId>
            <ArticleId IdType="pubmed">12488767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perkins T., Rosenberg J.M., Coz C.L., Alaimo J.T., Trofa M. Smith-Magenis Syndrome Patients Often Display Antibody Deficiency but Not Other Immune Pathologies. J. Allergy Clin. Immunol. Pract. 2017;5:1344–1350.e3. doi: 10.1016/j.jaip.2017.01.028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaip.2017.01.028</ArticleId>
            <ArticleId IdType="pmc">PMC5591748</ArticleId>
            <ArticleId IdType="pubmed">28286158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith A.C.M., Groptnan A.L., Bailey-Wilson J.E., Goker-Alpan O., Elsea S.H., Blancato J., Lupski J.R., Potocki L. Hypercholesterolemia in Children with Smith-Magenis Syndrome: Del (17)(p11.2p11.2) Genet. Med. 2002;4:118–125. doi: 10.1097/00125817-200205000-00004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00125817-200205000-00004</ArticleId>
            <ArticleId IdType="pubmed">12180145</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmidt L.S., Linehan W.M. Molecular Genetics and Clinical Features of Birt-Hogg-Dubé Syndrome. Nat. Rev. Urol. 2015;12:558–569. doi: 10.1038/nrurol.2015.206.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrurol.2015.206</ArticleId>
            <ArticleId IdType="pmc">PMC5119524</ArticleId>
            <ArticleId IdType="pubmed">26334087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Truong H.T., Dudding T., Blanchard C.L., Elsea S.H. Frameshift Mutation Hotspot Identified in Smith-Magenis Syndrome: Case Report and Review of Literature. BMC Med. Genet. 2010;11:142.  doi: 10.1186/1471-2350-11-142.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2350-11-142</ArticleId>
            <ArticleId IdType="pmc">PMC2964533</ArticleId>
            <ArticleId IdType="pubmed">20932317</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith A.C.M., Fleming L.R., Piskorski A.M., Amin A., Phorphutkul C., de la Monte S., Stopa E., Introne W., Vilboux T., Duncan F., et al.  Deletion of 17p11.2 Encompasses FLCN with Increased Risk of Birt-Hogg-Dubé in Smith Magenis Syndrome: Recommendation for Cancer Screening. Abstract 2603S; Proceedings of the 63rd Annual Meeting of The American Society of Human Genetics; San Diego, CA, USA. 18–22 October 2014.</Citation>
        </Reference>
        <Reference>
          <Citation>Dardour L., Verleyen P., Lesage K., Holvoet M., Devriendt K. Bilateral Renal Tumors in an Adult Man with Smith-Magenis Syndrome: The Role of the FLCN Gene. Eur. J. Med. Genet. 2016;59:499–501. doi: 10.1016/j.ejmg.2016.09.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejmg.2016.09.005</ArticleId>
            <ArticleId IdType="pubmed">27633572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finucane B., Savatt J.M., Shimelis H., Girirajan S., Myers S.M. Birt-Hogg-Dubé Symptoms in Smith-Magenis Syndrome Include Pediatric-Onset Pneumothorax. Am. J. Med. Genet. Part A. 2021;185:1922–1924. doi: 10.1002/ajmg.a.62159.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.62159</ArticleId>
            <ArticleId IdType="pubmed">33666332</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolters P.L., Gropman A.L., Martin S.C., Smith M.R., Hildenbrand H.L., Brewer C.C., Smith A.C.M. Neurodevelopment of Children Under 3 Years of Age with Smith-Magenis Syndrome. Pediatr. Neurol. 2009;41:250–258. doi: 10.1016/j.pediatrneurol.2009.04.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pediatrneurol.2009.04.015</ArticleId>
            <ArticleId IdType="pmc">PMC2785222</ArticleId>
            <ArticleId IdType="pubmed">19748044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Madduri N., Peters S.U., Voigt R.G., Llorente A.M., Lupski J.R., Potocki L. Cognitive and Adaptive Behavior Profiles in Smith-Magenis Syndrome. J. Dev. Behav. Pediatr. 2006;27:188–192. doi: 10.1097/00004703-200606000-00002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00004703-200606000-00002</ArticleId>
            <ArticleId IdType="pubmed">16775514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Udwin O., Webber C., Horn I. Abilities and Attainment in Smith-Magenis Syndrome. Dev. Med. Child Neurol. 2001;43:823. doi: 10.1017/S0012162201001499.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S0012162201001499</ArticleId>
            <ArticleId IdType="pubmed">11769269</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin S.C., Wolters P.L., Smith A.C.M. Adaptive and Maladaptive Behavior in Children with Smith-Magenis Syndrome. J. Autism Dev. Disord. 2006;36:541–552. doi: 10.1007/s10803-006-0093-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10803-006-0093-2</ArticleId>
            <ArticleId IdType="pubmed">16570214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garayzábal Heinze E., Lens Villaverde M., Moruno López E., Conde Magro T., Moura L.F., Fernández M., Sampaio A. General cognitive functioning and psycholinguistic abilities in children with Smith-Magenis Syndrome. Psicothema. 2011;23:725–731.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22047865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dykens E.M., Finucane B.M., Gayley C. Brief Report: Cognitive and Behavioral Profiles in Persons with Smith-Magenis Syndrome. J. Autism Dev. Disord. 1997;27:203–211. doi: 10.1023/A:1025800126086.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/A:1025800126086</ArticleId>
            <ArticleId IdType="pubmed">9105971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Osório A., Cruz R., Sampaio A., Garayzábal E., Carracedo Á., Fernández-Prieto M. Cognitive Functioning in Children and Adults with Smith-Magenis Syndrome. Eur. J. Med. Genet. 2012;55:394–399. doi: 10.1016/j.ejmg.2012.04.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejmg.2012.04.001</ArticleId>
            <ArticleId IdType="pubmed">22579991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poisson A., Nicolas A., Cochat P., Sanlaville D., Rigard C., De Leersnyder H., Franco P., Portes V.D., Edery P., Demily C. Behavioral Disturbance and Treatment Strategies in Smith-Magenis Syndrome. Orphanet J. Rare Dis. 2015;10:111. doi: 10.1186/s13023-015-0330-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13023-015-0330-x</ArticleId>
            <ArticleId IdType="pmc">PMC4559928</ArticleId>
            <ArticleId IdType="pubmed">26336863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Laje G., Morse R., Richter W., Ball J., Pao M., Smith A.C.M. Autism Spectrum Features in Smith-Magenis Syndrome. Am. J. Med. Genet. Part C Semin. Med. Genet. 2010;154:456–462. doi: 10.1002/ajmg.c.30275.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.c.30275</ArticleId>
            <ArticleId IdType="pmc">PMC2967410</ArticleId>
            <ArticleId IdType="pubmed">20981775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nag H.E., Nordgren A., Anderlid B.-M., Nærland T. Reversed Gender Ratio of Autism Spectrum Disorder in Smith-Magenis Syndrome. Mol. Autism. 2018;9:1. doi: 10.1186/s13229-017-0184-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13229-017-0184-2</ArticleId>
            <ArticleId IdType="pmc">PMC5759230</ArticleId>
            <ArticleId IdType="pubmed">29321841</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bissell S., Wilde L., Richards C., Moss J., Oliver C. The Behavioural Phenotype of Potocki-Lupski Syndrome: A Cross-Syndrome Comparison. J. Neurodev. Disord. 2018;10:2. doi: 10.1186/s11689-017-9221-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s11689-017-9221-x</ArticleId>
            <ArticleId IdType="pmc">PMC5795277</ArticleId>
            <ArticleId IdType="pubmed">29329513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hildenbrand H.L., Smith A.C.M. Analysis of the Sensory Profile in Children with Smith-Magenis Syndrome. Phys. Occup. Ther. Pediatr. 2012;32:48–65. doi: 10.3109/01942638.2011.572152.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/01942638.2011.572152</ArticleId>
            <ArticleId IdType="pubmed">21599572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dykens E.M., Smith A.C.M. Distinctiveness and Correlates of Maladaptive Behaviour in Children and Adolescents with Smith-Magenis Syndrome. J. Intellect. Disabil. Res. 1998;42:481–489. doi: 10.1046/j.1365-2788.1998.4260481.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-2788.1998.4260481.x</ArticleId>
            <ArticleId IdType="pubmed">10030444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finucane B., Dirrigl K.H., Simon E.W. Characterization of Self-Injurious Behaviors in Children and Adults with Smith-Magenis Syndrome. Am. J. Ment. Retard. 2001;106:52–58. doi: 10.1352/0895-8017(2001)106&lt;0052:COSIBI&gt;2.0.CO;2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1352/0895-8017(2001)106&lt;0052:COSIBI&gt;2.0.CO;2</ArticleId>
            <ArticleId IdType="pubmed">11246713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nag H.E., Nærland T. Age-Related Changes in Behavioural and Emotional Problems in Smith–Magenis Syndrome Measured with the Developmental Behavior Checklist. J. Intellect. Disabil. 2020;25:429–440. doi: 10.1177/1744629519901056.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1744629519901056</ArticleId>
            <ArticleId IdType="pmc">PMC8649468</ArticleId>
            <ArticleId IdType="pubmed">31984836</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor L., Oliver C. The Behavioural Phenotype of Smith-Magenis Syndrome: Evidence for a Gene-Environment Interaction. J. Intellect. Disabil. Res. 2008;52:830–841. doi: 10.1111/j.1365-2788.2008.01066.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2788.2008.01066.x</ArticleId>
            <ArticleId IdType="pubmed">18466291</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finucane B., Haas-Givler B. Smith-Magenis Syndrome: Genetic Basis and Clinical Implications. J. Ment. Health Res. Intellect. Disabil. 2009;2:134–148. doi: 10.1080/19315860802627619.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/19315860802627619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shayota B.J., Elsea S.H. Behavior and Sleep Disturbance in Smith-Magenis Syndrome. Curr. Opin. Psychiatry. 2019;32:73–78. doi: 10.1097/YCO.0000000000000474.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/YCO.0000000000000474</ArticleId>
            <ArticleId IdType="pmc">PMC6362978</ArticleId>
            <ArticleId IdType="pubmed">30557269</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sloneem J., Oliver C., Udwin O., Woodcock K.A. Prevalence, Phenomenology, Aetiology and Predictors of Challenging Behaviour in Smith-Magenis Syndrome. J. Intellect. Disabil. Res. 2011;55:138–151. doi: 10.1111/j.1365-2788.2010.01371.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2788.2010.01371.x</ArticleId>
            <ArticleId IdType="pubmed">21199049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alaimo J.T., Barton L.V., Mullegama S.V., Wills R.D., Foster R.H., Elsea S.H. Individuals with Smith-Magenis Syndrome Display Profound Neurodevelopmental Behavioral Deficiencies and Exhibit Food-Related Behaviors Equivalent to Prader-Willi Syndrome. Res. Dev. Disabil. 2015;47:27–38. doi: 10.1016/j.ridd.2015.08.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ridd.2015.08.011</ArticleId>
            <ArticleId IdType="pubmed">26323055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finucane B.M., Konar D., Givler B.H., Kurtt M.B., Scott C.I. The Spasmodic Upper-body Squeeze: A Chalacteristic Behavior in Smith-Magenis Syndrome. Dev. Med. Child Neurol. 1994;36:78–83. doi: 10.1111/j.1469-8749.1994.tb11770.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1469-8749.1994.tb11770.x</ArticleId>
            <ArticleId IdType="pubmed">8132119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greenberg F., Magenis W., Finucane B.M., Smith A.C.M., Patel P.I., Lupski J.R. Smith-Magenis Syndrome [del(17)(p11.2)] and Its Clinical Overlap with Prader-Willi Syndrome. Abstract; Proceedings of the 45th Annual Meeting of The American Society of Human Genetics; San Francisco, CA, USA. 24–28 October 1996.</Citation>
        </Reference>
        <Reference>
          <Citation>Smith A.C.M., Dykens E., Greenberg F. Sleep Disturbance in Smith-Magenis Syndrome (del 17 p11.2) Am. J. Med. Genet. (Neuropsychiatr. Genet.) 1998;81:186–191. doi: 10.1002/(SICI)1096-8628(19980328)81:2&lt;186::AID-AJMG11&gt;3.0.CO;2-D.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1096-8628(19980328)81:2&lt;186::AID-AJMG11&gt;3.0.CO;2-D</ArticleId>
            <ArticleId IdType="pubmed">9613860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith A.C.M., Morse R.S., Introne W., Duncan W.C. Twenty-Four-Hour Motor Activity and Body Temperature Patterns Suggest Altered Central Circadian Timekeeping in Smith–Magenis Syndrome, a Neurodevelopmental Disorder. Am. J. Med. Genet. Part A. 2019;179:224–236. doi: 10.1002/ajmg.a.61003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.61003</ArticleId>
            <ArticleId IdType="pmc">PMC6699156</ArticleId>
            <ArticleId IdType="pubmed">30690916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agar G., Brown C., Sutherland D., Coulborn S., Oliver C., Richards C. Sleep Disorders in Rare Genetic Syndromes: A Meta-Analysis of Prevalence and Profile. Mol. Autism. 2021;12:18. doi: 10.1186/s13229-021-00426-w.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13229-021-00426-w</ArticleId>
            <ArticleId IdType="pmc">PMC7908701</ArticleId>
            <ArticleId IdType="pubmed">33632309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boudreau E.A., Johnson K.P., Jackman A.R., Blancato J., Huizing M., Bendavid C., Jones M.P., Chandrasekharappa S.C., Lewy A.J., Smith A.C.M., et al.  Review of Disrupted Sleep Patterns in Smith-Magenis Syndrome and Normal Melatonin Secretion in a Patient with an Atypical Interstitial 17p11.2 Deletion. Am. J. Med. Genet. Part A. 2009;149:1382–1391. doi: 10.1002/ajmg.a.32846.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.32846</ArticleId>
            <ArticleId IdType="pmc">PMC2760428</ArticleId>
            <ArticleId IdType="pubmed">19530184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Potocki L., Glaze D., Tan D.X., Park S.S., Kashork C.D., Shaffer L.G., Reiter R.J., Lupski J.R. Circadian Rhythm Abnormalities of Melatonin in Smith-Magenis Syndrome. J. Med. Genet. 2000;37:428–433. doi: 10.1136/jmg.37.6.428.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jmg.37.6.428</ArticleId>
            <ArticleId IdType="pmc">PMC1734604</ArticleId>
            <ArticleId IdType="pubmed">10851253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goldman A.M., Potocki L., Walz K., Lynch J.K., Glaze D.G., Lupski J.R., Noebels J.L. Epilepsy and Chromosomal Rearrangements in Smith-Magenis Syndrome [del(17)(p11.2p11.2)] J. Child Neurol. 2006;21:93–98. doi: 10.1177/08830738060210021201.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/08830738060210021201</ArticleId>
            <ArticleId IdType="pubmed">16566870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boddaert N., De Leersnyder H., Bourgeois M., Munnich A., Brunelle F., Zilbovicius M. Anatomical and Functional Brain Imaging Evidence of Lenticulo-Insular Anomalies in Smith Magenis Syndrome. NeuroImage. 2004;21:1021–1025. doi: 10.1016/j.neuroimage.2003.10.040.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroimage.2003.10.040</ArticleId>
            <ArticleId IdType="pubmed">15006669</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masuno M., Asano J., Arai M., Kuwahara T., Orii T. Interstitial Deletion of 17p11.2 with Brain Abnormalities. Clin. Genet. 2008;41:278–280. doi: 10.1111/j.1399-0004.1992.tb03682.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1399-0004.1992.tb03682.x</ArticleId>
            <ArticleId IdType="pubmed">1606718</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Natacci F., Corrado L., Pierri M., Rossetti M., Zuccarini C., Riva P., Miozzo M., Larizza L. Patient with Large 17p11.2 Deletion Presenting with Smith-Magenis Syndrome and Joubert Syndrome Phenotype. Am. J. Med. Genet. 2000;95:467–472. doi: 10.1002/1096-8628(20001218)95:5&lt;467::AID-AJMG11&gt;3.0.CO;2-T.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/1096-8628(20001218)95:5&lt;467::AID-AJMG11&gt;3.0.CO;2-T</ArticleId>
            <ArticleId IdType="pubmed">11146468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Capra V., Biancheri R., Morana G., Striano P., Novara F., Ferrero G.B., Boeri L., Celle M.E., Mancardi M.M., Zuffardi O., et al.  Periventricular Nodular Heterotopia in Smith-Magenis Syndrome. Am. J. Med. Genet. Part A. 2014;164:3142–3147. doi: 10.1002/ajmg.a.36742.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.36742</ArticleId>
            <ArticleId IdType="pubmed">25257626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Girirajan S., Mendoza-Londono R., Vlangos C.N., Dupuis L., Nowak N.J., Bunyan D.J., Hatchwell E., Elsea S.H. Smith-Magenis Syndrome and Moyamoya Disease in a Patient with del(17)(p11.2p13.1) Am. J. Med. Genet. Part A. 2007;143:999–1008. doi: 10.1002/ajmg.a.31689.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.31689</ArticleId>
            <ArticleId IdType="pubmed">17431895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaudhry A.P., Schwartz C., Singh A.K. Stroke after Cardiac Surgery in a Patient with Smith-Magenis Syndrome. Tex. Heart Inst. J. 2007;34:247–249.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1894707</ArticleId>
            <ArticleId IdType="pubmed">17622381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vlangos C. Refinement of the Smith–Magenis Syndrome Critical Region to ∼950 kb and Assessment of 17p11.2 Deletions. Are All Deletions Created Equally? Mol. Genet. Metab. 2003;79:134–141. doi: 10.1016/S1096-7192(03)00048-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1096-7192(03)00048-9</ArticleId>
            <ArticleId IdType="pubmed">12809645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elsea S.H., Williams S.R. Smith-Magenis Syndrome: Haploinsufficiency of RAI1 Results in Altered Gene Regulation in Neurological and Metabolic Pathways. Expert Rev. Mol. Med. 2011;13:e14. doi: 10.1017/S1462399411001827.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S1462399411001827</ArticleId>
            <ArticleId IdType="pubmed">21545756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lupski J.R., Stankiewicz P. Genomic Disorders: Molecular Mechanisms for Rearrangements and Conveyed Phenotypes. PLoS Genet. 2005;1:e49.  doi: 10.1371/journal.pgen.0010049.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pgen.0010049</ArticleId>
            <ArticleId IdType="pmc">PMC1352149</ArticleId>
            <ArticleId IdType="pubmed">16444292</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boot E., Linders C.C., Tromp S.H., van den Boogaard M.J., van Eeghen A.M. Possible Underreporting of Pathogenic Variants in RAI1 Causing Smith–Magenis Syndrome. Am. J. Med. Genet. Part A. 2021;185:3167–3169. doi: 10.1002/ajmg.a.62380.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.62380</ArticleId>
            <ArticleId IdType="pmc">PMC8519085</ArticleId>
            <ArticleId IdType="pubmed">34089220</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Falco M., Amabile S., Acquaviva F. RAI1 Gene Mutations: Mechanisms of Smith-Magenis Syndrome. Appl. Clin. Genet. 2017;10:85–94. doi: 10.2147/TACG.S128455.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/TACG.S128455</ArticleId>
            <ArticleId IdType="pmc">PMC5680963</ArticleId>
            <ArticleId IdType="pubmed">29138588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zori R.T., Lupski J.R., Heju Z., Greenberg F., Killian J.M., Gray B.A., Driscoll D.J., Patel P.I., Zackowski J.L. Clinical, Cytogenetic, and Molecular Evidence for an Infant with Smith–Magenis Syndrome Born from a Mother Having a Mosaic 17p11.2p12 Deletion. Am. J. Med. Genet. 1993;47:504–511. doi: 10.1002/ajmg.1320470414.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.1320470414</ArticleId>
            <ArticleId IdType="pubmed">8256814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang S.P., Bidichandani S.I., Figuera L.E., Juyal R.C., Saxon P.J., Baldini A., Patel P.I. Molecular Analysis of Deletion (17)(p11.2p11.2) in a Family Segregating a 17p Paracentric Inversion: Implications for Carriers of Paracentric Inversions. Am. J. Hum. Genet. 1997;60:1184–1193.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1712444</ArticleId>
            <ArticleId IdType="pubmed">9150166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Campbell I.M., Yuan B., Robberecht C., Pfundt R., Szafranski P., McEntagart M.E., Nagamani S.C.S., Erez A., Bartnik M., Wiśniowiecka-Kowalnik B., et al.  Parental Somatic Mosaicism Is Underrecognized and Influences Recurrence Risk of Genomic Disorders. Am. J. Hum. Genet. 2014;95:173–182. doi: 10.1016/j.ajhg.2014.07.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajhg.2014.07.003</ArticleId>
            <ArticleId IdType="pmc">PMC4129404</ArticleId>
            <ArticleId IdType="pubmed">25087610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park J.P., Moeschler J.B., Davies W.S., Patel P.I., Mohandas T.K. Smith-Magenis Syndrome Resulting from a de Novo Direct Insertion of Proximal 17q into 17p11.2. Am. J. Med. Genet. 1998;77:23–27. doi: 10.1002/(SICI)1096-8628(19980428)77:1&lt;23::AID-AJMG6&gt;3.0.CO;2-M.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1096-8628(19980428)77:1&lt;23::AID-AJMG6&gt;3.0.CO;2-M</ArticleId>
            <ArticleId IdType="pubmed">9557889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goh E.S.-Y., Banwell B., Stavropoulos D.J., Shago M., Yoon G. Mosaic Microdeletion of 17p11.2-P12 and Duplication of 17q22-Q24 in a Girl with Smith-Magenis Phenotype and Peripheral Neuropathy. Am. J. Med. Genet. A. 2014;164:748–752. doi: 10.1002/ajmg.a.36322.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.36322</ArticleId>
            <ArticleId IdType="pubmed">24357149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Acquaviva F., Sana M.E., Della Monica M., Pinelli M., Postorivo D., Fontana P., Falco M.T., Nardone A.M., Lonardo F., Iascone M., et al.  First Evidence of Smith-Magenis Syndrome in Mother and Daughter Due to a Novel RAI Mutation. Am. J. Med. Genet. A. 2017;173:231–238. doi: 10.1002/ajmg.a.37989.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.37989</ArticleId>
            <ArticleId IdType="pubmed">27683195</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carmona-Mora P., Walz K. Retinoic Acid Induced 1, RAI1: A Dosage Sensitive Gene Related to Neurobehavioral Alterations Including Autistic Behavior. Curr. Genom. 2010;11:607–617. doi: 10.2174/138920210793360952.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/138920210793360952</ArticleId>
            <ArticleId IdType="pmc">PMC3078685</ArticleId>
            <ArticleId IdType="pubmed">21629438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carmona-Mora P., Encina C.A., Canales C.P., Cao L., Molina J., Kairath P., Young J.I., Walz K. Functional and Cellular Characterization of Human Retinoic Acid Induced 1 (RAI1) Mutations Associated with Smith-Magenis Syndrome. BMC Mol. Biol. 2010;11:63.  doi: 10.1186/1471-2199-11-63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2199-11-63</ArticleId>
            <ArticleId IdType="pmc">PMC2939504</ArticleId>
            <ArticleId IdType="pubmed">20738874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Darvekar S., Johnsen S.S., Eriksen A.B., Johansen T., Sjøttem E. Identification of Two Independent Nucleosome-Binding Domains in the Transcriptional Co-Activator SPBP. Biochem. J. 2012;442:65–75. doi: 10.1042/BJ20111230.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/BJ20111230</ArticleId>
            <ArticleId IdType="pubmed">22081970</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Darvekar S., Rekdal C., Johansen T., Sjøttem E. A Phylogenetic Study of SPBP and RAI1: Evolutionary Conservation of Chromatin Binding Modules. PLoS ONE. 2013;8:e78907.  doi: 10.1371/journal.pone.0078907.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0078907</ArticleId>
            <ArticleId IdType="pmc">PMC3799622</ArticleId>
            <ArticleId IdType="pubmed">24205348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang W.-H., Guenthner C.J., Xu J., Nguyen T., Schwarz L.A., Wilkinson A.W., Gozani O., Chang H.Y., Shamloo M., Luo L. Molecular and Neural Functions of Rai1, the Causal Gene for Smith-Magenis Syndrome. Neuron. 2016;92:392–406. doi: 10.1016/j.neuron.2016.09.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2016.09.019</ArticleId>
            <ArticleId IdType="pmc">PMC5098476</ArticleId>
            <ArticleId IdType="pubmed">27693255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Milne T.A., Briggs S.D., Brock H.W., Martin M.E., Gibbs D., Allis C.D., Hess J.L. MLL Targets SET Domain Methyltransferase Activity to Hox Gene Promoters. Mol. Cell. 2002;10:1107–1117. doi: 10.1016/S1097-2765(02)00741-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1097-2765(02)00741-4</ArticleId>
            <ArticleId IdType="pubmed">12453418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakamura T., Mori T., Tada S., Krajewski W., Rozovskaia T., Wassell R., Dubois G., Mazo A., Croce C.M., Canaani E. ALL-1 Is a Histone Methyltransferase That Assembles a Supercomplex of Proteins Involved in Transcriptional Regulation. Mol. Cell. 2002;10:1119–1128. doi: 10.1016/S1097-2765(02)00740-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1097-2765(02)00740-2</ArticleId>
            <ArticleId IdType="pubmed">12453419</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bi W., Saifi G.M., Shaw C.J., Walz K., Fonseca P., Wilson M., Potocki L., Lupski J.R. Mutations of RAI1, a PHD-Containing Protein, in Nondeletion Patients with Smith-Magenis Syndrome. Hum. Genet. 2004;115:515–524. doi: 10.1007/s00439-004-1187-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00439-004-1187-6</ArticleId>
            <ArticleId IdType="pubmed">15565467</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garay P.M., Chen A., Tsukahara T., Rodríguez Díaz J.C., Kohen R., Althaus J.C., Wallner M.A., Giger R.J., Jones K.S., Sutton M.A., et al.  RAI1 Regulates Activity-Dependent Nascent Transcription and Synaptic Scaling. Cell Rep. 2020;32:108002. doi: 10.1016/j.celrep.2020.108002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2020.108002</ArticleId>
            <ArticleId IdType="pmc">PMC7418709</ArticleId>
            <ArticleId IdType="pubmed">32783930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams S.R., Zies D., Mullegama S.V., Grotewiel M.S., Elsea S.H. Smith-Magenis Syndrome Results in Disruption of CLOCK Gene Transcription and Reveals an Integral Role for RAI1 in the Maintenance of Circadian Rhythmicity. Am. J. Hum. Genet. 2012;90:941–949. doi: 10.1016/j.ajhg.2012.04.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajhg.2012.04.013</ArticleId>
            <ArticleId IdType="pmc">PMC3370274</ArticleId>
            <ArticleId IdType="pubmed">22578325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garay P.M., Wallner M.A., Iwase S. Yin–Yang Actions of Histone Methylation Regulatory Complexes in the Brain. Epigenomics. 2016;8:1689–1708. doi: 10.2217/epi-2016-0090.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2217/epi-2016-0090</ArticleId>
            <ArticleId IdType="pmc">PMC5289040</ArticleId>
            <ArticleId IdType="pubmed">27855486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eberl H.C., Spruijt C.G., Kelstrup C.D., Vermeulen M., Mann M. A Map of General and Specialized Chromatin Readers in Mouse Tissues Generated by Label-Free Interaction Proteomics. Mol. Cell. 2013;49:368–378. doi: 10.1016/j.molcel.2012.10.026.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molcel.2012.10.026</ArticleId>
            <ArticleId IdType="pubmed">23201125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones W.D., Dafou D., McEntagart M., Woollard W.J., Elmslie F.V., Holder-Espinasse M., Irving M., Saggar A.K., Smithson S., Trembath R.C., et al.  De Novo Mutations in MLL Cause Wiedemann-Steiner Syndrome. Am. J. Hum. Genet. 2012;91:358–364. doi: 10.1016/j.ajhg.2012.06.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajhg.2012.06.008</ArticleId>
            <ArticleId IdType="pmc">PMC3415539</ArticleId>
            <ArticleId IdType="pubmed">22795537</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Babbs C., Lloyd D., Pagnamenta A.T., Twigg S.R.F., Green J., McGowan S.J., Mirza G., Naples R., Sharma V.P., Volpi E.V., et al.  De Novo and Rare Inherited Mutations Implicate the Transcriptional Coregulator TCF20/SPBP in Autism Spectrum Disorder. J. Med. Genet. 2014;51:737–747. doi: 10.1136/jmedgenet-2014-102582.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jmedgenet-2014-102582</ArticleId>
            <ArticleId IdType="pmc">PMC4215269</ArticleId>
            <ArticleId IdType="pubmed">25228304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams S.R., Aldred M.A., Der Kaloustian V.M., Halal F., Gowans G., McLeod D.R., Zondag S., Toriello H.V., Magenis R.E., Elsea S.H. Haploinsufficiency of HDAC4 Causes Brachydactyly Mental Retardation Syndrome, with Brachydactyly Type E, Developmental Delays, and Behavioral Problems. Am. J. Hum. Genet. 2010;87:219–228. doi: 10.1016/j.ajhg.2010.07.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajhg.2010.07.011</ArticleId>
            <ArticleId IdType="pmc">PMC2917703</ArticleId>
            <ArticleId IdType="pubmed">20691407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams S.R., Mullegama S.V., Rosenfeld J.A., Dagli A.I., Hatchwell E., Allen W.P., Williams C.A., Elsea S.H. Haploinsufficiency of MBD5 Associated with a Syndrome Involving Microcephaly, Intellectual Disabilities, Severe Speech Impairment, and Seizures. Eur. J. Hum. Genet. 2010;18:436–441. doi: 10.1038/ejhg.2009.199.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ejhg.2009.199</ArticleId>
            <ArticleId IdType="pmc">PMC2987257</ArticleId>
            <ArticleId IdType="pubmed">19904302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Talkowski M.E., Mullegama S.V., Rosenfeld J.A., van Bon B.W.M., Shen Y., Repnikova E.A., Gastier-Foster J., Thrush D.L., Kathiresan S., Ruderfer D.M., et al.  Assessment of 2q23.1 Microdeletion Syndrome Implicates MBD5 as a Single Causal Locus of Intellectual Disability, Epilepsy, and Autism Spectrum Disorder. Am. J. Hum. Genet. 2011;89:551–563. doi: 10.1016/j.ajhg.2011.09.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajhg.2011.09.011</ArticleId>
            <ArticleId IdType="pmc">PMC3188839</ArticleId>
            <ArticleId IdType="pubmed">21981781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mullegama S.V., Alaimo J.T., Chen L., Elsea S.H. Phenotypic and Molecular Convergence of 2q23.1 Deletion Syndrome with Other Neurodevelopmental Syndromes Associated with Autism Spectrum Disorder. Int. J. Mol. Sci. 2015;16:7627–7643. doi: 10.3390/ijms16047627.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms16047627</ArticleId>
            <ArticleId IdType="pmc">PMC4425039</ArticleId>
            <ArticleId IdType="pubmed">25853262</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mullegama S.V., Pugliesi L., Burns B., Shah Z., Tahir R., Gu Y., Nelson D.L., Elsea S.H. MBD5 Haploinsufficiency Is Associated with Sleep Disturbance and Disrupts Circadian Pathways Common to Smith-Magenis and Fragile X Syndromes. Eur. J. Hum. Genet. 2015;23:781–789. doi: 10.1038/ejhg.2014.200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ejhg.2014.200</ArticleId>
            <ArticleId IdType="pmc">PMC4795052</ArticleId>
            <ArticleId IdType="pubmed">25271084</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kleefstra T., Kramer J.M., Neveling K., Willemsen M.H., Koemans T.S., Vissers L.E.L.M., Wissink-Lindhout W., Fenckova M., van den Akker W.M.R., Kasri N.N., et al.  Disruption of an EHMT1-Associated Chromatin-Modification Module Causes Intellectual Disability. Am. J. Hum. Genet. 2012;91:73–82. doi: 10.1016/j.ajhg.2012.05.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajhg.2012.05.003</ArticleId>
            <ArticleId IdType="pmc">PMC3397275</ArticleId>
            <ArticleId IdType="pubmed">22726846</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koemans T.S., Kleefstra T., Chubak M.C., Stone M.H., Reijnders M.R.F., de Munnik S., Willemsen M.H., Fenckova M., Stumpel C.T.R.M., Bok L.A., et al.  Functional Convergence of Histone Methyltransferases EHMT1 and KMT2C Involved in Intellectual Disability and Autism Spectrum Disorder. PLoS Genet. 2017;13:e1006864.  doi: 10.1371/journal.pgen.1006864.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pgen.1006864</ArticleId>
            <ArticleId IdType="pmc">PMC5656305</ArticleId>
            <ArticleId IdType="pubmed">29069077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kleefstra T., Brunner H.G., Amiel J., Oudakker A.R., Nillesen W.M., Magee A., Geneviève D., Cormier-Daire V., van Esch H., Fryns J.-P., et al.  Loss-of-Function Mutations in Euchromatin Histone Methyl Transferase 1 (EHMT1) Cause the 9q34 Subtelomeric Deletion Syndrome. Am. J. Hum. Genet. 2006;79:370–377. doi: 10.1086/505693.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/505693</ArticleId>
            <ArticleId IdType="pmc">PMC1559478</ArticleId>
            <ArticleId IdType="pubmed">16826528</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Benevento M., Iacono G., Selten M., Ba W., Oudakker A., Frega M., Keller J., Mancini R., Lewerissa E., Kleefstra T., et al.  Histone Methylation by the Kleefstra Syndrome Protein EHMT1 Mediates Homeostatic Synaptic Scaling. Neuron. 2016;91:341–355. doi: 10.1016/j.neuron.2016.06.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2016.06.003</ArticleId>
            <ArticleId IdType="pubmed">27373831</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iacono G., Dubos A., Méziane H., Benevento M., Habibi E., Mandoli A., Riet F., Selloum M., Feil R., Zhou H., et al.  Increased H3K9 Methylation and Impaired Expression of Protocadherins Are Associated with the Cognitive Dysfunctions of the Kleefstra Syndrome. Nucleic Acids Res. 2018;46:4950–4965. doi: 10.1093/nar/gky196.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gky196</ArticleId>
            <ArticleId IdType="pmc">PMC6007260</ArticleId>
            <ArticleId IdType="pubmed">29554304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Loviglio M.N., Beck C.R., White J.J., Leleu M., Harel T., Guex N., Niknejad A., Bi W., Chen E.S., Crespo I., et al.  Identification of a RAI1-Associated Disease Network through Integration of Exome Sequencing, Transcriptomics, and 3D Genomics. Genome Med. 2016;8:105. doi: 10.1186/s13073-016-0359-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13073-016-0359-z</ArticleId>
            <ArticleId IdType="pmc">PMC5088687</ArticleId>
            <ArticleId IdType="pubmed">27799067</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berger S.I., Ciccone C., Simon K.L., Malicdan M.C., Vilboux T., Billington C., Fischer R., Introne W.J., Gropman A., Blancato J.K., et al.  Exome Analysis of Smith–Magenis-like Syndrome Cohort Identifies de novo Likely Pathogenic Variants. Hum. Genet. 2017;136:409–420. doi: 10.1007/s00439-017-1767-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00439-017-1767-x</ArticleId>
            <ArticleId IdType="pmc">PMC5848494</ArticleId>
            <ArticleId IdType="pubmed">28213671</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vetrini F., McKee S., Rosenfeld J.A., Suri M., Lewis A.M., Nugent K.M., Roeder E., Littlejohn R.O., Holder S., Zhu W., et al.  De Novo and Inherited TCF20 Pathogenic Variants Are Associated with Intellectual Disability, Dysmorphic Features, Hypotonia, and Neurological Impairments with Similarities to Smith-Magenis Syndrome. Genome Med. 2019;11:12. doi: 10.1186/s13073-019-0623-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13073-019-0623-0</ArticleId>
            <ArticleId IdType="pmc">PMC6393995</ArticleId>
            <ArticleId IdType="pubmed">30819258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kerkhof J., Squeo G.M., McConkey H., Levy M.A., Piemontese M.R., Castori M., Accadia M., Biamino E., Della Monica M., Di Giacomo M.C., et al.  DNA Methylation Episignature Testing Improves Molecular Diagnosis of Mendelian Chromatinopathies. Genet. Med. 2022;24:51–60. doi: 10.1016/j.gim.2021.08.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.gim.2021.08.007</ArticleId>
            <ArticleId IdType="pubmed">34906459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aref-Eshghi E., Kerkhof J., Pedro V.P., Barat-Houari M., Ruiz-Pallares N., Andrau J.-C., Lacombe D., Van-Gils J., Fergelot P., Dubourg C., et al.  Evaluation of DNA Methylation Episignatures for Diagnosis and Phenotype Correlations in 42 Mendelian Neurodevelopmental Disorders. Am. J. Hum. Genet. 2020;106:356–370. doi: 10.1016/j.ajhg.2020.01.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajhg.2020.01.019</ArticleId>
            <ArticleId IdType="pmc">PMC7058829</ArticleId>
            <ArticleId IdType="pubmed">32109418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Laje G., Bernert R., Morse R., Pao M., Smith A.C.M. Pharmacological Treatment of Disruptive Behavior in Smith-Magenis Syndrome. Am. J. Med. Genet. Part C Semin. Med. Genet. 2010;154:463–468. doi: 10.1002/ajmg.c.30282.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.c.30282</ArticleId>
            <ArticleId IdType="pmc">PMC3022344</ArticleId>
            <ArticleId IdType="pubmed">20981776</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Müller A.R., Zinkstok J.R., Rommelse N.N.J., van de Ven P.M., Roes K.C.B., Wijburg F.A., de Rooij-Askes E., Linders C., Boot E., van Eeghen A.M. Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Patients with Smith–Magenis Syndrome: Protocol for a Series of N-of-1 Trials. Orphanet J. Rare Dis. 2021;16:380. doi: 10.1186/s13023-021-02003-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13023-021-02003-z</ArticleId>
            <ArticleId IdType="pmc">PMC8424817</ArticleId>
            <ArticleId IdType="pubmed">34496899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hagerman R.J. Psychopharmacological Interventions in Fragile X Syndrome, Fetal Alcohol Syndrome, Prader-Willi Syndrome, Angelman Syndrome, Smith-Magenis Syndrome, and Velocardiofacial Syndrome. Ment. Retard. Dev. Disabil. Res. Rev. 1999;5:305–313. doi: 10.1002/(SICI)1098-2779(1999)5:4&lt;305::AID-MRDD8&gt;3.0.CO;2-L.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1098-2779(1999)5:4&lt;305::AID-MRDD8&gt;3.0.CO;2-L</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Niederhofer H. Efficacy of Risperidone Treatment in Smith-Magenis Syndrome (del 17 pll. 2) Psychiatr. Danub. 2007;19:189–192.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17914318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaplan K.A., Elsea S.H., Potocki L. Management of Sleep Disturbances Associated with Smith-Magenis Syndrome. CNS Drugs. 2020;34:723–730. doi: 10.1007/s40263-020-00733-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s40263-020-00733-5</ArticleId>
            <ArticleId IdType="pubmed">32495322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams Buckley A., Hirtz D., Oskoui M., Armstrong M.J., Batra A., Bridgemohan C., Coury D., Dawson G., Donley D., Findling R.L., et al.  Practice Guideline: Treatment for Insomnia and Disrupted Sleep Behavior in Children and Adolescents with Autism Spectrum Disorder. Neurology. 2020;94:392–404. doi: 10.1212/WNL.0000000000009033.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000009033</ArticleId>
            <ArticleId IdType="pmc">PMC7238942</ArticleId>
            <ArticleId IdType="pubmed">32051244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Leersnyder H., Bresson J.L., de Blois M.-C., Souberbielle J.-C., Mogenet A., Delhotal-Landes B., Salefranque F., Munnich A. Beta 1-Adrenergic Antagonists and Melatonin Reset the Clock and Restore Sleep in a Circadian Disorder, Smith-Magenis Syndrome. J. Med. Genet. 2003;40:74–78. doi: 10.1136/jmg.40.1.74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jmg.40.1.74</ArticleId>
            <ArticleId IdType="pmc">PMC1735264</ArticleId>
            <ArticleId IdType="pubmed">12525548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Polymeropoulos C.M., Brooks J., Czeisler E.L., Fisher M.A., Gibson M.M., Kite K., Smieszek S.P., Xiao C., Elsea S.H., Birznieks G., et al.  Tasimelteon Safely and Effectively Improves Sleep in Smith-Magenis Syndrome: A Double-Blind Randomized Trial Followed by an Open-Label Extension. Genet. Med. 2021;23:2426–2432. doi: 10.1038/s41436-021-01282-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41436-021-01282-y</ArticleId>
            <ArticleId IdType="pmc">PMC8629754</ArticleId>
            <ArticleId IdType="pubmed">34316024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richardson G.S., Zee P.C., Wang-Weigand S., Rodriguez L., Peng X. Circadian Phase-Shifting Effects of Repeated Ramelteon Administration in Healthy Adults. J. Clin. Sleep Med. 2008;4:456–461. doi: 10.5664/jcsm.27282.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5664/jcsm.27282</ArticleId>
            <ArticleId IdType="pmc">PMC2576313</ArticleId>
            <ArticleId IdType="pubmed">18853704</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
